{"protocolSection": {"identificationModule": {"nctId": "NCT01462344", "orgStudyIdInfo": {"id": "115358"}, "organization": {"fullName": "GlaxoSmithKline", "class": "INDUSTRY"}, "briefTitle": "6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old", "officialTitle": "A 6-month Safety and Benefit Study of Inhaled Fluticasone Propionate/ Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of 6,200 Pediatric Subjects 4-11 Years Old With Persistent Asthma", "acronym": "VESTRI"}, "statusModule": {"statusVerifiedDate": "2018-08", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-11-17"}, "primaryCompletionDateStruct": {"date": "2015-11-01", "type": "ACTUAL"}, "completionDateStruct": {"date": "2015-11-03", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-10-27", "studyFirstSubmitQcDate": "2011-10-27", "studyFirstPostDateStruct": {"date": "2011-10-31", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2016-05-02", "resultsFirstSubmitQcDate": "2016-08-11", "resultsFirstPostDateStruct": {"date": "2016-10-05", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2018-08-02", "lastUpdatePostDateStruct": {"date": "2018-08-06", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "GlaxoSmithKline", "class": "INDUSTRY"}, "collaborators": [{"name": "Parexel", "class": "INDUSTRY"}]}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "The purpose of this study is to assess whether the risk of serious asthma-related events (asthma-related hospitalizations, endotracheal intubations, and deaths) in children 4-11 years old taking inhaled fluticasone propionate/salmeterol combination is the same as those taking inhaled fluticasone propionate alone.", "detailedDescription": "Progress of Enrollment, Updated Annually: This study has been completed and the final clinical study report was submitted to the FDA in May of 2016. This is the final update, as this study is complete."}, "conditionsModule": {"conditions": ["Asthma"], "keywords": ["pediatric", "ADVAIR", "FLOVENT", "asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 6250, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "ADVAIR 100/50mcg", "type": "EXPERIMENTAL", "description": "fluticasone propionate/salmeterol combination (100/50mcg) twice daily (AM and PM) for 6 months", "interventionNames": ["Drug: ADVAIR 100/50mcg"]}, {"label": "ADVAIR 250/50mcg", "type": "EXPERIMENTAL", "description": "fluticasone propionate/salmeterol combination (250/50mcg) twice daily (AM and PM) for 6 months", "interventionNames": ["Drug: ADVAIR 250/50mcg"]}, {"label": "FLOVENT 100mcg", "type": "ACTIVE_COMPARATOR", "description": "fluticasone propionate (100) twice daily (AM and PM) for 6 months", "interventionNames": ["Drug: FLOVENT 100mcg"]}, {"label": "FLOVENT 250mcg", "type": "ACTIVE_COMPARATOR", "description": "fluticasone propionate (250mcg) twice daily (AM and PM) for 6 months", "interventionNames": ["Drug: FLOVENT 250mcg"]}], "interventions": [{"type": "DRUG", "name": "ADVAIR 100/50mcg", "description": "fluticasone propionate/salmeterol combination (100/50mcg) twice daily (AM and PM) for 6 months", "armGroupLabels": ["ADVAIR 100/50mcg"], "otherNames": ["FSC 100/50"]}, {"type": "DRUG", "name": "ADVAIR 250/50mcg", "description": "fluticasone propionate/salmeterol combination (250/50mcg) twice daily (AM and PM) for 6 months", "armGroupLabels": ["ADVAIR 250/50mcg"], "otherNames": ["FSC 250/50"]}, {"type": "DRUG", "name": "FLOVENT 100mcg", "description": "fluticasone propionate (100) twice daily (AM and PM) for 6 months", "armGroupLabels": ["FLOVENT 100mcg"], "otherNames": ["FP 100"]}, {"type": "DRUG", "name": "FLOVENT 250mcg", "description": "fluticasone propionate (250mcg) twice daily (AM and PM) for 6 months", "armGroupLabels": ["FLOVENT 250mcg"], "otherNames": ["FP 250"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants Experiencing an Event in the Composite Safety Endpoint of Serious Asthma Outcomes ( Asthma-related Hospitalization, Asthma-related Endotracheal Intubation, or Asthma-related Death)", "description": "Composite endpoint was defined as clinically relevant endpoint that is constructed from combinations of other clinically relevant endpoints of serious asthma outcomes (i.e., asthma-related hospitalization, asthma-related endotracheal intubation, or asthma-related death). Hospitalization was defined as an inpatient stay or a \\>=24-hour stay in an observation area in an emergency department or other equivalent facility. Time to first event in the composite endpoint of serious asthma-related outcomes over the 6-month study treatment period was analyzed using a Cox proportional hazards regression model. An estimate of absolute risk difference and its corresponding 95% confidence interval (CI) were also included. The Intent-to-Treat (ITT) Population included all participants randomized to study drug and who took study treatment.", "timeFrame": "From Day 1 up to 6 months"}, {"measure": "Number of Participants With at Least One Asthma Exacerbation Over the 6-month Study Treatment Period", "description": "Number of participants with asthma exacerbation over the 6-month study treatment period are presented. Participants from mITT population with screening childhood asthma control test (C-ACT) scores of 20 or higher, one exacerbation in the previous year, and either low-dose inhaled corticosteroid (ICS) + one or more adjunctive therapy or medium-dose ICS monotherapy or medium-dose ICS and one or more adjunctive therapy as prior asthma therapy were included for this endpoint. Time to first exacerbation analyzed using a cox proportional hazards regression model. The number of asthma exacerbations were compared between treatments using a negative binomial regression model. The modified Intent-to-Treat (mITT) Population consisted of the ITT participants with a different data cut-off for supportive analyses of the primary composite safety endpoint.", "timeFrame": "From Day 1 up to 6 months"}], "secondaryOutcomes": [{"measure": "Number of Participants Experiencing Asthma-related Deaths Over the 6-month Study Treatment Period.", "description": "Number of participants experiencing asthma-related death over the 6-month study treatment period are presented.", "timeFrame": "From Day 1 up to 6 months"}, {"measure": "Number of Participants Experiencing Asthma-related Endotracheal Intubations Over the 6-month Study Treatment Period", "description": "Intubation is defined as endotracheal intubation with ventilation (mechanical or by hand). The number of participants experiencing asthma-related endotracheal intubations over the 6-month study treatment period are presented.", "timeFrame": "From Day 1 up to 6 months"}, {"measure": "Number of Participants Experiencing Asthma-related Hospitalizations Over the 6-month Study Treatment Period", "description": "Hospitalization is defined as a \\>=24-hour stay as an inpatient or in an observation ward. The number of participants experiencing asthma-related hospitalizations over the 6-month study treatment period are presented.", "timeFrame": "From Day 1 up to 6 months"}, {"measure": "Number of Participants Withdrawn From Study Treatment Due to Asthma Exacerbation Over the 6-month Study Treatment Period", "description": "An exacerbation is defined as deterioration of asthma requiring the use of systemic corticosteroids (tablets, suspension, or injection) for at least 3 days (up to 10 days) or a single depot corticosteroid injection. Number of participants experiencing at least one exacerbation from mITT population were included for this endpoint. The number of participants withdrawn from study treatment due to asthma exacerbation over the 6-month study treatment period are presented.", "timeFrame": "From Day 1 up to 6 months"}, {"measure": "Percentage of Rescue-free Days Over the 6-month Study Treatment Period", "description": "Rescue-free days were days without use of rescue albuterol/salbutamol (other than pre-exercise treatment) over the 6-month study treatment period. The mean percentages of rescue-free days over the months 1-6 (defined as treatment days 2-182) are summarized. Number of participants over treatment days 2-182 from mITT Population were included for this endpoint.", "timeFrame": "From Day 1 up to 6 months"}, {"measure": "Percentage of Asthma Control Days Over the 6-month Study Treatment Period", "description": "An asthma control day is one on which rescue albuterol/salbutamol use was recorded as 0, no night time awakenings were recorded, no asthma exacerbations were recorded, no work, school, or daycare days were missed by caregiver or participant due to asthma, coughing symptom score was \\<=1 and wheezing symptom score was 0. The mean percentages of asthma control days over the months 1-6 (defined as treatment days 2-182) are summarized. Number of participants over treatment days 2-182 from mITT Population were included for this endpoint.", "timeFrame": "From Day 1 up to 6 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n1. Consent to participate in the study\n2. Age 4-11 years old\n3. Male or eligible female - Female subjects should not be enrolled if they are pregnant, lactating or plan to become pregnant during the time of study participation\n4. Asthma diagnosis for at least 6 months\n5. Ability to answer questions regarding asthma control and use a metered dose inhaler and DISKUS\n6. A history of clinical varicella infection or recipient of a varicella vaccine in countries where the product label includes a warning regarding more serious chickenpox infections in patients using corticosteroids.\n7. History of at least once occurrence of asthma exacerbation within the prior 12 months\n8. Currently being treated for asthma and no change in asthma therapy for the last 4 weeks (Eligible subjects include: subjects with use of short-acting beta-agonist, leukotriene receptor antagonist, theophylline, or cromolyn whose asthma is not well-controlled; subjects on low-dose ICS monotherapy whose asthma is not well-controlled; subjects on low-dose ICS and one or more adjunctive therapy whose asthma is either controlled or not well-controlled asthma; subjects on medium-dose ICS monotherapy whose asthma is either controlled or not well-controlled; and subjects on medium-dose ICS and one or more adjunctive therapy whose asthma is well-controlled)\n\nExclusion Criteria:\n\n1. History of life-threatening asthma\n2. Unstable asthma\n3. Current use of high-dose ICS or ICS/LABA therapy to treat asthma symptoms\n4. Concurrent respiratory disease: Current evidence of pneumonia, pneumothorax, atelectasis, pulmonary fibrotic disease, allergic bronchopulmonary aspergillosis, cystic fibrosis, bronchopulmonary dysplasia, or other severe respiratory abnormalities other than asthma.\n5. Respiratory infection\n6. Subjects with only exercise-induced asthma\n7. An asthma exacerbation within the last 4 weeks or more than 4 separate exacerbations in the last 12 months\n8. Hospitalization for asthma within 4 weeks or more than 2 hospitalizations within the last 12 months\n9. Other current evidence of clinically significant uncontrolled disease/conditions of any body or organ system\n10. Neurological or psychiatric disease or history of drug or alcohol abuse of a subject or his/her guardian which in the opinion of the investigator could interfere with the subject's proper completion of the protocol requirements\n11. Participation in an interventional study or used any investigational drug for any disease state within the last 30 days\n12. Any adverse reaction including immediate or delayed hypersensitivity to any beta-agonist, sympathomimetic drug, or any intranasal, inhaled, or systemic corticosteroid therapy, or vehicle contained within these medication\n13. Severe hypersensitivity to cow's milk proteins\n14. Administration of prescription or over the counter medications that would significantly affect the course of asthma, or interact with sympathomimetic amines such as: anti-IgE (omalizumab), anticonvulsants (barbiturates, hydantoins, carbamazepine); polycyclic antidepressants, beta-adrenergic blockers; phenothiazines, monoamine oxidase inhibitors, or diuretics\n15. Potent cytochrome P450 3A4 (CYP3A4) inhibitors within the last 4 weeks (e.g., ritonavir, ketoconazole, itraconzole)\n16. Affiliation with investigator's site, including a immediate family member of the participating investigator, sub-investigator, study coordinator, or employee of the participating investigator.\n17. A Child in Care (CiC) is a child who has been placed under the control or protection of an agency, organisation, institution or entity by the courts, the government or a government body, acting in accordance with powers conferred on them by law or regulation.", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "4 Years", "maximumAge": "11 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "GSK Clinical Trials", "affiliation": "GlaxoSmithKline", "role": "STUDY_DIRECTOR"}], "locations": [{"facility": "GSK Investigational Site", "city": "Birmingham", "state": "Alabama", "zip": "35209", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "GSK Investigational Site", "city": "Birmingham", "state": "Alabama", "zip": "35233", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"facility": "GSK Investigational Site", "city": "Mobile", "state": "Alabama", "zip": "36608", "country": "United States", "geoPoint": {"lat": 30.69436, "lon": -88.04305}}, {"facility": "GSK Investigational Site", "city": "Montgomery", "state": "Alabama", "zip": "36109", "country": "United States", "geoPoint": {"lat": 32.36681, "lon": -86.29997}}, {"facility": "GSK Investigational Site", "city": "Scottsboro", "state": "Alabama", "zip": "35768", "country": "United States", "geoPoint": {"lat": 34.67231, "lon": -86.03415}}, {"facility": "GSK Investigational Site", "city": "Toney", "state": "Alabama", "zip": "35773", "country": "United States", "geoPoint": {"lat": 34.89814, "lon": -86.73361}}, {"facility": "GSK Investigational Site", "city": "Tuscaloosa", "state": "Alabama", "zip": "35401", "country": "United States", "geoPoint": {"lat": 33.20984, "lon": -87.56917}}, {"facility": "GSK Investigational Site", "city": "Dothan", "state": "Alaska", "zip": "36305", "country": "United States"}, {"facility": "GSK Investigational Site", "city": "Chandler", "state": "Arizona", "zip": "85224", "country": "United States", "geoPoint": {"lat": 33.30616, "lon": -111.84125}}, {"facility": "GSK Investigational Site", "city": "Phoenix", "state": "Arizona", "zip": "85020", "country": "United States", "geoPoint": {"lat": 33.44838, "lon": -112.07404}}, {"facility": "GSK Investigational Site", "city": "Scottsdale", "state": "Arizona", "zip": "85255", "country": "United States", "geoPoint": {"lat": 33.50921, "lon": -111.89903}}, {"facility": "GSK Investigational Site", "city": "Scottsdale", "state": "Arizona", "zip": "85288", "country": "United States", "geoPoint": {"lat": 33.50921, "lon": -111.89903}}, {"facility": "GSK Investigational Site", "city": "Tucson", "state": "Arizona", "zip": "85724-5073", "country": "United States", "geoPoint": {"lat": 32.22174, "lon": -110.92648}}, {"facility": "GSK Investigational Site", "city": "Tucson", "state": "Arizona", "zip": "85741", "country": "United States", "geoPoint": {"lat": 32.22174, "lon": -110.92648}}, {"facility": "GSK Investigational Site", "city": "Bentonville", "state": "Arkansas", "zip": "72712", "country": "United States", "geoPoint": {"lat": 36.37285, "lon": -94.20882}}, {"facility": "GSK Investigational Site", "city": "Little Rock", "state": "Arkansas", "zip": "72204", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "GSK Investigational Site", "city": "Little Rock", "state": "Arkansas", "zip": "72205", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "GSK Investigational Site", "city": "Little Rock", "state": "Arkansas", "zip": "72209", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"facility": "GSK Investigational Site", "city": "Alhambra", "state": "California", "zip": "91801", "country": "United States", "geoPoint": {"lat": 34.09529, "lon": -118.12701}}, {"facility": "GSK Investigational Site", "city": "Bakersfield", "state": "California", "zip": "93301", "country": "United States", "geoPoint": {"lat": 35.37329, "lon": -119.01871}}, {"facility": "GSK Investigational Site", "city": "Canoga Park", "state": "California", "zip": "91306", "country": "United States", "geoPoint": {"lat": 34.20112, "lon": -118.59814}}, {"facility": "GSK Investigational Site", "city": "Dinuba", "state": "California", "zip": "93618", "country": "United States", "geoPoint": {"lat": 36.54328, "lon": -119.38707}}, {"facility": "GSK Investigational Site", "city": "Fresno", "state": "California", "zip": "93703", "country": "United States", "geoPoint": {"lat": 36.74773, "lon": -119.77237}}, {"facility": "GSK Investigational Site", "city": "Fresno", "state": "California", "zip": "93720", "country": "United States", "geoPoint": {"lat": 36.74773, "lon": -119.77237}}, {"facility": "GSK Investigational Site", "city": "Gold River", "state": "California", "zip": "95670", "country": "United States", "geoPoint": {"lat": 38.62629, "lon": -121.24662}}, {"facility": "GSK Investigational Site", "city": "Granada Hills", "state": "California", "zip": "91344", "country": "United States", "geoPoint": {"lat": 34.26472, "lon": -118.52314}}, {"facility": "GSK Investigational Site", "city": "Harbor City", "state": "California", "zip": "90710", "country": "United States", "geoPoint": {"lat": 33.79002, "lon": -118.29785}}, {"facility": "GSK Investigational Site", "city": "Huntington Beach", "state": "California", "zip": "92647", "country": "United States", "geoPoint": {"lat": 33.6603, "lon": -117.99923}}, {"facility": "GSK Investigational Site", "city": "Huntington Park", "state": "California", "zip": "90255", "country": "United States", "geoPoint": {"lat": 33.98168, "lon": -118.22507}}, {"facility": "GSK Investigational Site", "city": "Long Beach", "state": "California", "zip": "90807", "country": "United States", "geoPoint": {"lat": 33.76696, "lon": -118.18923}}, {"facility": "GSK Investigational Site", "city": "Long Beach", "state": "California", "zip": "90808", "country": "United States", "geoPoint": {"lat": 33.76696, "lon": -118.18923}}, {"facility": "GSK Investigational Site", "city": "Long Beach", "state": "California", "zip": "90813", "country": "United States", "geoPoint": {"lat": 33.76696, "lon": -118.18923}}, {"facility": "GSK Investigational Site", "city": "Los Angeles", "state": "California", "zip": "90057", "country": "United States", "geoPoint": {"lat": 34.05223, "lon": -118.24368}}, {"facility": "GSK Investigational Site", "city": "Napa", "state": "California", "zip": "94558", "country": "United States", "geoPoint": {"lat": 38.29714, "lon": -122.28553}}, {"facility": "GSK Investigational Site", "city": "Newport Beach", "state": "California", "zip": "92660", "country": "United States", "geoPoint": {"lat": 33.61891, "lon": -117.92895}}, {"facility": "GSK Investigational Site", "city": "Newport Beach", "state": "California", "zip": "92663", "country": "United States", "geoPoint": {"lat": 33.61891, "lon": -117.92895}}, {"facility": "GSK Investigational Site", "city": "Oakland", "state": "California", "zip": "94609", "country": "United States", "geoPoint": {"lat": 37.80437, "lon": -122.2708}}, {"facility": "GSK Investigational Site", "city": "Orange", "state": "California", "zip": "92868", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -117.85311}}, {"facility": "GSK Investigational Site", "city": "Palmdale", "state": "California", "zip": "93551", "country": "United States", "geoPoint": {"lat": 34.57943, "lon": -118.11646}}, {"facility": "GSK Investigational Site", "city": "Paramount", "state": "California", "zip": "90723", "country": "United States", "geoPoint": {"lat": 33.88946, "lon": -118.15979}}, {"facility": "GSK Investigational Site", "city": "Riverside", "state": "California", "zip": "92501", "country": "United States", "geoPoint": {"lat": 33.95335, "lon": -117.39616}}, {"facility": "GSK Investigational Site", "city": "Rolling Hills Est.", "state": "California", "zip": "920274", "country": "United States"}, {"facility": "GSK Investigational Site", "city": "Rolling Hills Estates", "state": "California", "zip": "90274", "country": "United States", "geoPoint": {"lat": 33.78779, "lon": -118.35813}}, {"facility": "GSK Investigational Site", "city": "Roseville", "state": "California", "zip": "95678", "country": "United States", "geoPoint": {"lat": 38.75212, "lon": -121.28801}}, {"facility": "GSK Investigational Site", "city": "Sacramento", "state": "California", "zip": "95825", "country": "United States", "geoPoint": {"lat": 38.58157, "lon": -121.4944}}, {"facility": "GSK Investigational Site", "city": "San Marino", "state": "California", "zip": "91108", "country": "United States", "geoPoint": {"lat": 34.1214, "lon": -118.10646}}, {"facility": "GSK Investigational Site", "city": "Santa Monica", "state": "California", "zip": "90404", "country": "United States", "geoPoint": {"lat": 34.01945, "lon": -118.49119}}, {"facility": "GSK Investigational Site", "city": "West Covina", "state": "California", "zip": "91790", "country": "United States", "geoPoint": {"lat": 34.06862, "lon": -117.93895}}, {"facility": "GSK Investigational Site", "city": "West Sacramento", "state": "California", "zip": "95691", "country": "United States", "geoPoint": {"lat": 38.58046, "lon": -121.53023}}, {"facility": "GSK Investigational Site", "city": "Aurora", "state": "Colorado", "zip": "80045", "country": "United States", "geoPoint": {"lat": 39.72943, "lon": -104.83192}}, {"facility": "GSK Investigational Site", "city": "Centennial", "state": "Colorado", "zip": "80112", "country": "United States", "geoPoint": {"lat": 39.57916, "lon": -104.87692}}, {"facility": "GSK Investigational Site", "city": "Colorado Springs", "state": "Colorado", "zip": "80907", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "GSK Investigational Site", "city": "Colorado Springs", "state": "Colorado", "zip": "80920", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "GSK Investigational Site", "city": "Colorado Springs", "state": "Colorado", "zip": "80922", "country": "United States", "geoPoint": {"lat": 38.83388, "lon": -104.82136}}, {"facility": "GSK Investigational Site", "city": "Denver", "state": "Colorado", "zip": "80206", "country": "United States", "geoPoint": {"lat": 39.73915, "lon": -104.9847}}, {"facility": "GSK Investigational Site", "city": "Waterbury", "state": "Connecticut", "zip": "06708", "country": "United States", "geoPoint": {"lat": 41.55815, "lon": -73.0515}}, {"facility": "GSK Investigational Site", "city": "Washington", "state": "District of Columbia", "zip": "20037", "country": "United States", "geoPoint": {"lat": 38.89511, "lon": -77.03637}}, {"facility": "GSK Investigational Site", "city": "Aventura", "state": "Florida", "zip": "33180", "country": "United States", "geoPoint": {"lat": 25.95648, "lon": -80.13921}}, {"facility": "GSK Investigational Site", "city": "Boynton Beach", "state": "Florida", "zip": "33435", "country": "United States", "geoPoint": {"lat": 26.52535, "lon": -80.06643}}, {"facility": "GSK Investigational Site", "city": "Cocoa", "state": "Florida", "zip": "32927", "country": "United States", "geoPoint": {"lat": 28.38612, "lon": -80.742}}, {"facility": "GSK Investigational Site", "city": "Coral Gables", "state": "Florida", "zip": "33134", "country": "United States", "geoPoint": {"lat": 25.72149, "lon": -80.26838}}, {"facility": "GSK Investigational Site", "city": "Destin", "state": "Florida", "zip": "32541", "country": "United States", "geoPoint": {"lat": 30.39353, "lon": -86.49578}}, {"facility": "GSK Investigational Site", "city": "Doral", "state": "Florida", "zip": "33172", "country": "United States", "geoPoint": {"lat": 25.81954, "lon": -80.35533}}, {"facility": "GSK Investigational Site", "city": "Gainesville", "state": "Florida", "zip": "32605", "country": "United States", "geoPoint": {"lat": 29.65163, "lon": -82.32483}}, {"facility": "GSK Investigational Site", "city": "Gainesville", "state": "Florida", "zip": "32610", "country": "United States", "geoPoint": {"lat": 29.65163, "lon": -82.32483}}, {"facility": "GSK Investigational Site", "city": "Hialeah", "state": "Florida", "zip": "33012", "country": "United States", "geoPoint": {"lat": 25.8576, "lon": -80.27811}}, {"facility": "GSK Investigational Site", "city": "Melbourne", "state": "Florida", "zip": "32935", "country": "United States", "geoPoint": {"lat": 28.08363, "lon": -80.60811}}, {"facility": "GSK Investigational Site", "city": "Miami Lakes", "state": "Florida", "zip": "33016", "country": "United States", "geoPoint": {"lat": 25.90871, "lon": -80.30866}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33126", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33135", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33142", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33144", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33156", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33173", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33175", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33176", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Miami", "state": "Florida", "zip": "33184", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"facility": "GSK Investigational Site", "city": "Naples", "state": "Florida", "zip": "34102", "country": "United States", "geoPoint": {"lat": 26.14234, "lon": -81.79596}}, {"facility": "GSK Investigational Site", "city": "New Port Richey", "state": "Florida", "zip": "34652", "country": "United States", "geoPoint": {"lat": 28.24418, "lon": -82.71927}}, {"facility": "GSK Investigational Site", "city": "Ocala", "state": "Florida", "zip": "34471", "country": "United States", "geoPoint": {"lat": 29.1872, "lon": -82.14009}}, {"facility": "GSK Investigational Site", "city": "Orlando", "state": "Florida", "zip": "32806", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "GSK Investigational Site", "city": "Orlando", "state": "Florida", "zip": "32811", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "GSK Investigational Site", "city": "Orlando", "state": "Florida", "zip": "32822", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"facility": "GSK Investigational Site", "city": "Pace", "state": "Florida", "zip": "32571", "country": "United States", "geoPoint": {"lat": 30.59936, "lon": -87.16108}}, {"facility": "GSK Investigational Site", "city": "Pensacola", "state": "Florida", "zip": "32503", "country": "United States", "geoPoint": {"lat": 30.42131, "lon": -87.21691}}, {"facility": "GSK Investigational Site", "city": "Pensacola", "state": "Florida", "zip": "32514", "country": "United States", "geoPoint": {"lat": 30.42131, "lon": -87.21691}}, {"facility": "GSK Investigational Site", "city": "Ponte Vedra Beach", "state": "Florida", "zip": "32081", "country": "United States", "geoPoint": {"lat": 30.23969, "lon": -81.38564}}, {"facility": "GSK Investigational Site", "city": "Saint Cloud", "state": "Florida", "zip": "34769", "country": "United States", "geoPoint": {"lat": 28.2489, "lon": -81.28118}}, {"facility": "GSK Investigational Site", "city": "Saint Petersburg", "state": "Florida", "zip": "33701", "country": "United States", "geoPoint": {"lat": 27.77086, "lon": -82.67927}}, {"facility": "GSK Investigational Site", "city": "Saint Petersburg", "state": "Florida", "zip": "33710", "country": "United States", "geoPoint": {"lat": 27.77086, "lon": -82.67927}}, {"facility": "GSK Investigational Site", "city": "Tampa", "state": "Florida", "zip": "33606", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "GSK Investigational Site", "city": "Tampa", "state": "Florida", "zip": "33613", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"facility": "GSK Investigational Site", "city": "Wellington", "state": "Florida", "zip": "33414", "country": "United States", "geoPoint": {"lat": 26.65868, "lon": -80.24144}}, {"facility": "GSK Investigational Site", "city": "Augusta", "state": "Georgia", "zip": "30909", "country": "United States", "geoPoint": {"lat": 33.47097, "lon": -81.97484}}, {"facility": "GSK Investigational Site", "city": "Calhoun", "state": "Georgia", "zip": "30701", "country": "United States", "geoPoint": {"lat": 34.50259, "lon": -84.95105}}, {"facility": "GSK Investigational Site", "city": "Columbus", "state": "Georgia", "zip": "31904", "country": "United States", "geoPoint": {"lat": 32.46098, "lon": -84.98771}}, {"facility": "GSK Investigational Site", "city": "Gainesville", "state": "Georgia", "zip": "30501", "country": "United States", "geoPoint": {"lat": 34.29788, "lon": -83.82407}}, {"facility": "GSK Investigational Site", "city": "Lawrenceville", "state": "Georgia", "zip": "30045", "country": "United States", "geoPoint": {"lat": 33.95621, "lon": -83.98796}}, {"facility": "GSK Investigational Site", "city": "Lilburn", "state": "Georgia", "zip": "30047", "country": "United States", "geoPoint": {"lat": 33.8901, "lon": -84.14297}}, {"facility": "GSK Investigational Site", "city": "Savannah", "state": "Georgia", "zip": "31406", "country": "United States", "geoPoint": {"lat": 32.08354, "lon": -81.09983}}, {"facility": "GSK Investigational Site", "city": "Stockbridge", "state": "Georgia", "zip": "30281", "country": "United States", "geoPoint": {"lat": 33.54428, "lon": -84.23381}}, {"facility": "GSK Investigational Site", "city": "Chicago", "state": "Illinois", "zip": "60616", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"facility": "GSK Investigational Site", "city": "Evergreen Park", "state": "Illinois", "zip": "60805", "country": "United States", "geoPoint": {"lat": 41.72059, "lon": -87.70172}}, {"facility": "GSK Investigational Site", "city": "Glenview", "state": "Illinois", "zip": "60025", "country": "United States", "geoPoint": {"lat": 42.06975, "lon": -87.78784}}, {"facility": "GSK Investigational Site", "city": "Normal", "state": "Illinois", "zip": "61761", "country": "United States", "geoPoint": {"lat": 40.5142, "lon": -88.99063}}, {"facility": "GSK Investigational Site", "city": "Shiloh", "state": "Illinois", "zip": "62269", "country": "United States", "geoPoint": {"lat": 38.56144, "lon": -89.89732}}, {"facility": "GSK Investigational Site", "city": "Crown Point", "state": "Indiana", "zip": "46307", "country": "United States", "geoPoint": {"lat": 41.41698, "lon": -87.36531}}, {"facility": "GSK Investigational Site", "city": "Evansville", "state": "Indiana", "zip": "47713", "country": "United States", "geoPoint": {"lat": 37.97476, "lon": -87.55585}}, {"facility": "GSK Investigational Site", "city": "Evansville", "state": "Indiana", "zip": "47714", "country": "United States", "geoPoint": {"lat": 37.97476, "lon": -87.55585}}, {"facility": "GSK Investigational Site", "city": "Indianapolis", "state": "Indiana", "zip": "46202", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "GSK Investigational Site", "city": "Indianapolis", "state": "Indiana", "zip": "46208", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "GSK Investigational Site", "city": "Indianapolis", "state": "Indiana", "zip": "46256", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"facility": "GSK Investigational Site", "city": "West Des Moines", "state": "Iowa", "zip": "50265", "country": "United States", "geoPoint": {"lat": 41.57721, "lon": -93.71133}}, {"facility": "GSK Investigational Site", "city": "Overland Park", "state": "Kansas", "zip": "66210", "country": "United States", "geoPoint": {"lat": 38.98223, "lon": -94.67079}}, {"facility": "GSK Investigational Site", "city": "Lexington", "state": "Kentucky", "zip": "40508", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "GSK Investigational Site", "city": "Lexington", "state": "Kentucky", "zip": "40509", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"facility": "GSK Investigational Site", "city": "Louisville", "state": "Kentucky", "zip": "40291", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"facility": "GSK Investigational Site", "city": "Owensboro", "state": "Kentucky", "zip": "42301", "country": "United States", "geoPoint": {"lat": 37.77422, "lon": -87.11333}}, {"facility": "GSK Investigational Site", "city": "Metairie", "state": "Louisiana", "zip": "70006", "country": "United States", "geoPoint": {"lat": 29.98409, "lon": -90.15285}}, {"facility": "GSK Investigational Site", "city": "Shreveport", "state": "Louisiana", "zip": "71106", "country": "United States", "geoPoint": {"lat": 32.52515, "lon": -93.75018}}, {"facility": "GSK Investigational Site", "city": "Bangor", "state": "Maine", "zip": "04401", "country": "United States", "geoPoint": {"lat": 44.80118, "lon": -68.77781}}, {"facility": "GSK Investigational Site", "city": "Largo", "state": "Maryland", "zip": "20774", "country": "United States", "geoPoint": {"lat": 38.89761, "lon": -76.83025}}, {"facility": "GSK Investigational Site", "city": "Silver Spring", "state": "Maryland", "zip": "20910", "country": "United States", "geoPoint": {"lat": 38.99067, "lon": -77.02609}}, {"facility": "GSK Investigational Site", "city": "White Marsh", "state": "Maryland", "zip": "21162", "country": "United States", "geoPoint": {"lat": 39.38372, "lon": -76.43218}}, {"facility": "GSK Investigational Site", "city": "Fall River", "state": "Massachusetts", "zip": "02720", "country": "United States", "geoPoint": {"lat": 41.70149, "lon": -71.15505}}, {"facility": "GSK Investigational Site", "city": "Buckley", "state": "Michigan", "zip": "49620", "country": "United States", "geoPoint": {"lat": 44.50445, "lon": -85.67701}}, {"facility": "GSK Investigational Site", "city": "Fenton", "state": "Michigan", "zip": "48430", "country": "United States", "geoPoint": {"lat": 42.79781, "lon": -83.70495}}, {"facility": "GSK Investigational Site", "city": "Niles", "state": "Michigan", "zip": "49120", "country": "United States", "geoPoint": {"lat": 41.82977, "lon": -86.25418}}, {"facility": "GSK Investigational Site", "city": "Stevensville", "state": "Michigan", "zip": "49127", "country": "United States", "geoPoint": {"lat": 42.01449, "lon": -86.51947}}, {"facility": "GSK Investigational Site", "city": "Ypsilanti", "state": "Michigan", "zip": "48197", "country": "United States", "geoPoint": {"lat": 42.24115, "lon": -83.61299}}, {"facility": "GSK Investigational Site", "city": "Plymouth", "state": "Minnesota", "zip": "55441", "country": "United States", "geoPoint": {"lat": 45.01052, "lon": -93.45551}}, {"facility": "GSK Investigational Site", "city": "Port Gibson", "state": "Mississippi", "zip": "39150", "country": "United States", "geoPoint": {"lat": 31.96099, "lon": -90.98399}}, {"facility": "GSK Investigational Site", "city": "Kansas City", "state": "Missouri", "zip": "64108", "country": "United States", "geoPoint": {"lat": 39.09973, "lon": -94.57857}}, {"facility": "GSK Investigational Site", "city": "Kansas City", "state": "Missouri", "zip": "64114", "country": "United States", "geoPoint": {"lat": 39.09973, "lon": -94.57857}}, {"facility": "GSK Investigational Site", "city": "Kansas City", "state": "Missouri", "zip": "64138", "country": "United States", "geoPoint": {"lat": 39.09973, "lon": -94.57857}}, {"facility": "GSK Investigational Site", "city": "Warrensburg", "state": "Missouri", "zip": "64093", "country": "United States", "geoPoint": {"lat": 38.76279, "lon": -93.73605}}, {"facility": "GSK Investigational Site", "city": "Billings", "state": "Montana", "zip": "59101", "country": "United States", "geoPoint": {"lat": 45.78329, "lon": -108.50069}}, {"facility": "GSK Investigational Site", "city": "Great Falls", "state": "Montana", "zip": "59405", "country": "United States", "geoPoint": {"lat": 47.50024, "lon": -111.30081}}, {"facility": "GSK Investigational Site", "city": "Missoula", "state": "Montana", "zip": "59808", "country": "United States", "geoPoint": {"lat": 46.87215, "lon": -113.994}}, {"facility": "GSK Investigational Site", "city": "Bellevue", "state": "Nebraska", "zip": "68005", "country": "United States", "geoPoint": {"lat": 41.13667, "lon": -95.89084}}, {"facility": "GSK Investigational Site", "city": "Bellevue", "state": "Nebraska", "zip": "68123-4303", "country": "United States", "geoPoint": {"lat": 41.13667, "lon": -95.89084}}, {"facility": "GSK Investigational Site", "city": "Lincoln", "state": "Nebraska", "zip": "68516", "country": "United States", "geoPoint": {"lat": 40.8, "lon": -96.66696}}, {"facility": "GSK Investigational Site", "city": "Omaha", "state": "Nebraska", "zip": "68130", "country": "United States", "geoPoint": {"lat": 41.25626, "lon": -95.94043}}, {"facility": "GSK Investigational Site", "city": "Las Vegas", "state": "Nevada", "zip": "89106", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"facility": "GSK Investigational Site", "city": "Las Vegas", "state": "Nevada", "zip": "89107", "country": "United States", "geoPoint": {"lat": 36.17497, "lon": -115.13722}}, {"facility": "GSK Investigational Site", "city": "Brick", "state": "New Jersey", "zip": "8724", "country": "United States", "geoPoint": {"lat": 40.05928, "lon": -74.13708}}, {"facility": "GSK Investigational Site", "city": "Edison", "state": "New Jersey", "zip": "08817", "country": "United States", "geoPoint": {"lat": 40.51872, "lon": -74.4121}}, {"facility": "GSK Investigational Site", "city": "Edison", "state": "New Jersey", "zip": "08820", "country": "United States", "geoPoint": {"lat": 40.51872, "lon": -74.4121}}, {"facility": "GSK Investigational Site", "city": "Livingston", "state": "New Jersey", "zip": "07039", "country": "United States", "geoPoint": {"lat": 40.79593, "lon": -74.31487}}, {"facility": "GSK Investigational Site", "city": "Marlton", "state": "New Jersey", "zip": "08053", "country": "United States", "geoPoint": {"lat": 39.89122, "lon": -74.92183}}, {"facility": "GSK Investigational Site", "city": "Northfield", "state": "New Jersey", "zip": "8225", "country": "United States", "geoPoint": {"lat": 39.37039, "lon": -74.55015}}, {"facility": "GSK Investigational Site", "city": "Ocean City", "state": "New Jersey", "zip": "07712", "country": "United States", "geoPoint": {"lat": 39.27762, "lon": -74.5746}}, {"facility": "GSK Investigational Site", "city": "Somerville", "state": "New Jersey", "zip": "8876", "country": "United States", "geoPoint": {"lat": 40.57427, "lon": -74.60988}}, {"facility": "GSK Investigational Site", "city": "Verona", "state": "New Jersey", "zip": "07044", "country": "United States", "geoPoint": {"lat": 40.82982, "lon": -74.24015}}, {"facility": "GSK Investigational Site", "city": "Albuquerque", "state": "New Mexico", "zip": "87109", "country": "United States", "geoPoint": {"lat": 35.08449, "lon": -106.65114}}, {"facility": "GSK Investigational Site", "city": "Albuquerque", "state": "New Mexico", "zip": "87131", "country": "United States", "geoPoint": {"lat": 35.08449, "lon": -106.65114}}, {"facility": "GSK Investigational Site", "city": "Astoria", "state": "New York", "zip": "11103", "country": "United States", "geoPoint": {"lat": 40.77205, "lon": -73.93014}}, {"facility": "GSK Investigational Site", "city": "Bronx", "state": "New York", "zip": "10461", "country": "United States", "geoPoint": {"lat": 40.84985, "lon": -73.86641}}, {"facility": "GSK Investigational Site", "city": "Great Neck", "state": "New York", "zip": "11023", "country": "United States", "geoPoint": {"lat": 40.80066, "lon": -73.72846}}, {"facility": "GSK Investigational Site", "city": "Johnson City", "state": "New York", "zip": "13790", "country": "United States", "geoPoint": {"lat": 42.11563, "lon": -75.95881}}, {"facility": "GSK Investigational Site", "city": "Newburgh", "state": "New York", "zip": "12550", "country": "United States", "geoPoint": {"lat": 41.50343, "lon": -74.01042}}, {"facility": "GSK Investigational Site", "city": "North Syracuse", "state": "New York", "zip": "13212", "country": "United States", "geoPoint": {"lat": 43.13479, "lon": -76.12992}}, {"facility": "GSK Investigational Site", "city": "Staten Island", "state": "New York", "zip": "10304", "country": "United States", "geoPoint": {"lat": 40.56233, "lon": -74.13986}}, {"facility": "GSK Investigational Site", "city": "Utica", "state": "New York", "zip": "13502", "country": "United States", "geoPoint": {"lat": 43.1009, "lon": -75.23266}}, {"facility": "GSK Investigational Site", "city": "Westfield", "state": "New York", "zip": "14787", "country": "United States", "geoPoint": {"lat": 42.32228, "lon": -79.5781}}, {"facility": "GSK Investigational Site", "city": "Asheboro", "state": "North Carolina", "zip": "27203", "country": "United States", "geoPoint": {"lat": 35.70791, "lon": -79.81364}}, {"facility": "GSK Investigational Site", "city": "Asheville", "state": "North Carolina", "zip": "28801", "country": "United States", "geoPoint": {"lat": 35.60095, "lon": -82.55402}}, {"facility": "GSK Investigational Site", "city": "Clyde", "state": "North Carolina", "zip": "28721", "country": "United States", "geoPoint": {"lat": 35.53344, "lon": -82.91069}}, {"facility": "GSK Investigational Site", "city": "High Point", "state": "North Carolina", "zip": "27262", "country": "United States", "geoPoint": {"lat": 35.95569, "lon": -80.00532}}, {"facility": "GSK Investigational Site", "city": "Shelby", "state": "North Carolina", "zip": "28152", "country": "United States", "geoPoint": {"lat": 35.29235, "lon": -81.53565}}, {"facility": "GSK Investigational Site", "city": "Fargo", "state": "North Dakota", "zip": "58104", "country": "United States", "geoPoint": {"lat": 46.87719, "lon": -96.7898}}, {"facility": "GSK Investigational Site", "city": "Akron", "state": "Ohio", "zip": "44308-1062", "country": "United States", "geoPoint": {"lat": 41.08144, "lon": -81.51901}}, {"facility": "GSK Investigational Site", "city": "Beavercreek", "state": "Ohio", "zip": "45431", "country": "United States", "geoPoint": {"lat": 39.70923, "lon": -84.06327}}, {"facility": "GSK Investigational Site", "city": "Canton", "state": "Ohio", "zip": "44718", "country": "United States", "geoPoint": {"lat": 40.79895, "lon": -81.37845}}, {"facility": "GSK Investigational Site", "city": "Centerville", "state": "Ohio", "zip": "45458", "country": "United States", "geoPoint": {"lat": 39.62839, "lon": -84.15938}}, {"facility": "GSK Investigational Site", "city": "Cincinnati", "state": "Ohio", "zip": "45231", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"facility": "GSK Investigational Site", "city": "Cleveland", "state": "Ohio", "zip": "44130", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"facility": "GSK Investigational Site", "city": "Dayton", "state": "Ohio", "zip": "45406", "country": "United States", "geoPoint": {"lat": 39.75895, "lon": -84.19161}}, {"facility": "GSK Investigational Site", "city": "Dayton", "state": "Ohio", "zip": "45432", "country": "United States", "geoPoint": {"lat": 39.75895, "lon": -84.19161}}, {"facility": "GSK Investigational Site", "city": "Marion", "state": "Ohio", "zip": "43302", "country": "United States", "geoPoint": {"lat": 40.58867, "lon": -83.12852}}, {"facility": "GSK Investigational Site", "city": "Shaker Heights", "state": "Ohio", "zip": "44120", "country": "United States", "geoPoint": {"lat": 41.47394, "lon": -81.53707}}, {"facility": "GSK Investigational Site", "city": "Sylvania", "state": "Ohio", "zip": "43560", "country": "United States", "geoPoint": {"lat": 41.71894, "lon": -83.71299}}, {"facility": "GSK Investigational Site", "city": "Toledo", "state": "Ohio", "zip": "43606", "country": "United States", "geoPoint": {"lat": 41.66394, "lon": -83.55521}}, {"facility": "GSK Investigational Site", "city": "Toledo", "state": "Ohio", "zip": "43617", "country": "United States", "geoPoint": {"lat": 41.66394, "lon": -83.55521}}, {"facility": "GSK Investigational Site", "city": "Wheeling", "state": "Ohio", "zip": "26003", "country": "United States"}, {"facility": "GSK Investigational Site", "city": "Zanesville", "state": "Ohio", "zip": "43701", "country": "United States", "geoPoint": {"lat": 39.94035, "lon": -82.01319}}, {"facility": "GSK Investigational Site", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73112", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "GSK Investigational Site", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73120", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "GSK Investigational Site", "city": "Oklahoma City", "state": "Oklahoma", "zip": "73131", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"facility": "GSK Investigational Site", "city": "Ashland", "state": "Oregon", "zip": "97520", "country": "United States", "geoPoint": {"lat": 42.19458, "lon": -122.70948}}, {"facility": "GSK Investigational Site", "city": "Gresham", "state": "Oregon", "zip": "97030", "country": "United States", "geoPoint": {"lat": 45.49818, "lon": -122.43148}}, {"facility": "GSK Investigational Site", "city": "Lake Oswego", "state": "Oregon", "zip": "97035", "country": "United States", "geoPoint": {"lat": 45.42067, "lon": -122.67065}}, {"facility": "GSK Investigational Site", "city": "Belle Vernon", "state": "Pennsylvania", "zip": "15012", "country": "United States", "geoPoint": {"lat": 40.12507, "lon": -79.86644}}, {"facility": "GSK Investigational Site", "city": "Blue Bell", "state": "Pennsylvania", "zip": "19422", "country": "United States", "geoPoint": {"lat": 40.15233, "lon": -75.26629}}, {"facility": "GSK Investigational Site", "city": "Johnstown", "state": "Pennsylvania", "zip": "15904", "country": "United States", "geoPoint": {"lat": 40.32674, "lon": -78.92197}}, {"facility": "GSK Investigational Site", "city": "Latrobe", "state": "Pennsylvania", "zip": "15650", "country": "United States", "geoPoint": {"lat": 40.32118, "lon": -79.37948}}, {"facility": "GSK Investigational Site", "city": "Pittsburgh", "state": "Pennsylvania", "zip": "15212", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"facility": "GSK Investigational Site", "city": "Shippensburg", "state": "Pennsylvania", "zip": "17257", "country": "United States", "geoPoint": {"lat": 40.05065, "lon": -77.52026}}, {"facility": "GSK Investigational Site", "city": "Lincoln", "state": "Rhode Island", "zip": "2865", "country": "United States", "geoPoint": {"lat": 41.92111, "lon": -71.435}}, {"facility": "GSK Investigational Site", "city": "Charleston", "state": "South Carolina", "zip": "29406", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "GSK Investigational Site", "city": "Charleston", "state": "South Carolina", "zip": "29407", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "GSK Investigational Site", "city": "Columbia", "state": "South Carolina", "zip": "29203", "country": "United States", "geoPoint": {"lat": 34.00071, "lon": -81.03481}}, {"facility": "GSK Investigational Site", "city": "Fort Mill", "state": "South Carolina", "zip": "29707", "country": "United States", "geoPoint": {"lat": 35.00737, "lon": -80.94508}}, {"facility": "GSK Investigational Site", "city": "Greenville", "state": "South Carolina", "zip": "29607", "country": "United States", "geoPoint": {"lat": 34.85262, "lon": -82.39401}}, {"facility": "GSK Investigational Site", "city": "Chattanooga", "state": "Tennessee", "zip": "37411", "country": "United States", "geoPoint": {"lat": 35.04563, "lon": -85.30968}}, {"facility": "GSK Investigational Site", "city": "Chattanooga", "state": "Tennessee", "zip": "37421", "country": "United States", "geoPoint": {"lat": 35.04563, "lon": -85.30968}}, {"facility": "GSK Investigational Site", "city": "Germantown", "state": "Tennessee", "zip": "38138", "country": "United States", "geoPoint": {"lat": 35.08676, "lon": -89.81009}}, {"facility": "GSK Investigational Site", "city": "McKenzie", "state": "Tennessee", "zip": "38201", "country": "United States", "geoPoint": {"lat": 36.13256, "lon": -88.51866}}, {"facility": "GSK Investigational Site", "city": "Nashville", "state": "Tennessee", "zip": "37203", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "GSK Investigational Site", "city": "Nashville", "state": "Tennessee", "zip": "37214", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "GSK Investigational Site", "city": "Shelbyville", "state": "Tennessee", "zip": "37160", "country": "United States", "geoPoint": {"lat": 35.48341, "lon": -86.46027}}, {"facility": "GSK Investigational Site", "city": "Allen", "state": "Texas", "zip": "75013", "country": "United States", "geoPoint": {"lat": 33.10317, "lon": -96.67055}}, {"facility": "GSK Investigational Site", "city": "Arlington", "state": "Texas", "zip": "76018", "country": "United States", "geoPoint": {"lat": 32.73569, "lon": -97.10807}}, {"facility": "GSK Investigational Site", "city": "Austin", "state": "Texas", "zip": "78759-8950", "country": "United States", "geoPoint": {"lat": 30.26715, "lon": -97.74306}}, {"facility": "GSK Investigational Site", "city": "Corsicana", "state": "Texas", "zip": "75110", "country": "United States", "geoPoint": {"lat": 32.09543, "lon": -96.46887}}, {"facility": "GSK Investigational Site", "city": "Dallas", "state": "Texas", "zip": "75225", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "GSK Investigational Site", "city": "Dallas", "state": "Texas", "zip": "75230", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "GSK Investigational Site", "city": "Dallas", "state": "Texas", "zip": "75246", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "GSK Investigational Site", "city": "Dickinson", "state": "Texas", "zip": "77539", "country": "United States", "geoPoint": {"lat": 29.46079, "lon": -95.05132}}, {"facility": "GSK Investigational Site", "city": "Duncanville", "state": "Texas", "zip": "75116", "country": "United States", "geoPoint": {"lat": 32.6518, "lon": -96.90834}}, {"facility": "GSK Investigational Site", "city": "El Paso", "state": "Texas", "zip": "79925", "country": "United States", "geoPoint": {"lat": 31.75872, "lon": -106.48693}}, {"facility": "GSK Investigational Site", "city": "Gun Barrel City", "state": "Texas", "zip": "75156", "country": "United States", "geoPoint": {"lat": 32.33459, "lon": -96.15136}}, {"facility": "GSK Investigational Site", "city": "Houston", "state": "Texas", "zip": "77036", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "GSK Investigational Site", "city": "Houston", "state": "Texas", "zip": "77055", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "GSK Investigational Site", "city": "Houston", "state": "Texas", "zip": "77077", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"facility": "GSK Investigational Site", "city": "Irving", "state": "Texas", "zip": "75039", "country": "United States", "geoPoint": {"lat": 32.81402, "lon": -96.94889}}, {"facility": "GSK Investigational Site", "city": "Katy", "state": "Texas", "zip": "77450", "country": "United States", "geoPoint": {"lat": 29.78579, "lon": -95.8244}}, {"facility": "GSK Investigational Site", "city": "Killeen", "state": "Texas", "zip": "76542", "country": "United States", "geoPoint": {"lat": 31.11712, "lon": -97.7278}}, {"facility": "GSK Investigational Site", "city": "Kingwood", "state": "Texas", "zip": "77339", "country": "United States", "geoPoint": {"lat": 30.03355, "lon": -95.26104}}, {"facility": "GSK Investigational Site", "city": "Lewisville", "state": "Texas", "zip": "75067", "country": "United States", "geoPoint": {"lat": 33.04623, "lon": -96.99417}}, {"facility": "GSK Investigational Site", "city": "Live Oak", "state": "Texas", "zip": "78233", "country": "United States", "geoPoint": {"lat": 29.56523, "lon": -98.3364}}, {"facility": "GSK Investigational Site", "city": "Lufkin", "state": "Texas", "zip": "75904", "country": "United States", "geoPoint": {"lat": 31.33824, "lon": -94.7291}}, {"facility": "GSK Investigational Site", "city": "San Antonio", "state": "Texas", "zip": "78207", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "GSK Investigational Site", "city": "San Antonio", "state": "Texas", "zip": "78224", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "GSK Investigational Site", "city": "San Antonio", "state": "Texas", "zip": "78228", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "GSK Investigational Site", "city": "San Antonio", "state": "Texas", "zip": "78229", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "GSK Investigational Site", "city": "San Antonio", "state": "Texas", "zip": "78251", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "GSK Investigational Site", "city": "San Antonio", "state": "Texas", "zip": "78299", "country": "United States", "geoPoint": {"lat": 29.42412, "lon": -98.49363}}, {"facility": "GSK Investigational Site", "city": "Sealy", "state": "Texas", "zip": "77474", "country": "United States", "geoPoint": {"lat": 29.78079, "lon": -96.15718}}, {"facility": "GSK Investigational Site", "city": "Sugar Land", "state": "Texas", "zip": "77478", "country": "United States", "geoPoint": {"lat": 29.61968, "lon": -95.63495}}, {"facility": "GSK Investigational Site", "city": "Sugar Land", "state": "Texas", "zip": "77479", "country": "United States", "geoPoint": {"lat": 29.61968, "lon": -95.63495}}, {"facility": "GSK Investigational Site", "city": "Tomball", "state": "Texas", "zip": "77375", "country": "United States", "geoPoint": {"lat": 30.09716, "lon": -95.61605}}, {"facility": "GSK Investigational Site", "city": "Tyler", "state": "Texas", "zip": "75708", "country": "United States", "geoPoint": {"lat": 32.35126, "lon": -95.30106}}, {"facility": "GSK Investigational Site", "city": "Waco", "state": "Texas", "zip": "76710", "country": "United States", "geoPoint": {"lat": 31.54933, "lon": -97.14667}}, {"facility": "GSK Investigational Site", "city": "Waco", "state": "Texas", "zip": "76712", "country": "United States", "geoPoint": {"lat": 31.54933, "lon": -97.14667}}, {"facility": "GSK Investigational Site", "city": "Waxahachie", "state": "Texas", "zip": "75165", "country": "United States", "geoPoint": {"lat": 32.38653, "lon": -96.84833}}, {"facility": "GSK Investigational Site", "city": "Clinton", "state": "Utah", "zip": "84015", "country": "United States", "geoPoint": {"lat": 41.13967, "lon": -112.0505}}, {"facility": "GSK Investigational Site", "city": "Draper", "state": "Utah", "zip": "84020", "country": "United States", "geoPoint": {"lat": 40.52467, "lon": -111.86382}}, {"facility": "GSK Investigational Site", "city": "Layton", "state": "Utah", "zip": "84041", "country": "United States", "geoPoint": {"lat": 41.06022, "lon": -111.97105}}, {"facility": "GSK Investigational Site", "city": "Murray", "state": "Utah", "zip": "84107", "country": "United States", "geoPoint": {"lat": 40.66689, "lon": -111.88799}}, {"facility": "GSK Investigational Site", "city": "Woods Cross", "state": "Utah", "zip": "84087", "country": "United States", "geoPoint": {"lat": 40.87161, "lon": -111.89216}}, {"facility": "GSK Investigational Site", "city": "Charlottesville", "state": "Virginia", "zip": "22902", "country": "United States", "geoPoint": {"lat": 38.02931, "lon": -78.47668}}, {"facility": "GSK Investigational Site", "city": "Hampton", "state": "Virginia", "zip": "23666", "country": "United States", "geoPoint": {"lat": 37.02987, "lon": -76.34522}}, {"facility": "GSK Investigational Site", "city": "Midlothian", "state": "Virginia", "zip": "23113", "country": "United States", "geoPoint": {"lat": 37.50598, "lon": -77.64916}}, {"facility": "GSK Investigational Site", "city": "Midlothian", "state": "Virginia", "zip": "23114", "country": "United States", "geoPoint": {"lat": 37.50598, "lon": -77.64916}}, {"facility": "GSK Investigational Site", "city": "Norfolk", "state": "Virginia", "zip": "23507", "country": "United States", "geoPoint": {"lat": 36.84681, "lon": -76.28522}}, {"facility": "GSK Investigational Site", "city": "Richmond", "state": "Virginia", "zip": "23223", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "GSK Investigational Site", "city": "Richmond", "state": "Virginia", "zip": "23226", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "GSK Investigational Site", "city": "Richmond", "state": "Virginia", "zip": "23235", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"facility": "GSK Investigational Site", "city": "Virginia Beach", "state": "Virginia", "zip": "23454", "country": "United States", "geoPoint": {"lat": 36.85293, "lon": -75.97799}}, {"facility": "GSK Investigational Site", "city": "Bellingham", "state": "Washington", "zip": "98225", "country": "United States", "geoPoint": {"lat": 48.75955, "lon": -122.48822}}, {"facility": "GSK Investigational Site", "city": "Puyallup", "state": "Washington", "zip": "98371", "country": "United States", "geoPoint": {"lat": 47.18538, "lon": -122.2929}}, {"facility": "GSK Investigational Site", "city": "Wenatchee", "state": "Washington", "zip": "98801", "country": "United States", "geoPoint": {"lat": 47.42346, "lon": -120.31035}}, {"facility": "GSK Investigational Site", "city": "Greenfield", "state": "Wisconsin", "zip": "53228", "country": "United States", "geoPoint": {"lat": 42.9614, "lon": -88.01259}}, {"facility": "GSK Investigational Site", "city": "La Crosse", "state": "Wisconsin", "zip": "54601", "country": "United States", "geoPoint": {"lat": 43.80136, "lon": -91.23958}}, {"facility": "GSK Investigational Site", "city": "Madison", "state": "Wisconsin", "zip": "53792-9988", "country": "United States", "geoPoint": {"lat": 43.07305, "lon": -89.40123}}, {"facility": "GSK Investigational Site", "city": "Milwaukee", "state": "Wisconsin", "zip": "53226", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}, {"facility": "GSK Investigational Site", "city": "Ciudad Autonoma de Buenos Aires", "state": "Buenos Aires", "zip": "C1122AAK", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "GSK Investigational Site", "city": "Mar del Plata", "state": "Buenos Aires", "zip": "7600", "country": "Argentina", "geoPoint": {"lat": -38.00228, "lon": -57.55754}}, {"facility": "GSK Investigational Site", "city": "Nueve de Julio", "state": "Buenos Aires", "zip": "B6500BWQ", "country": "Argentina", "geoPoint": {"lat": -35.44437, "lon": -60.88313}}, {"facility": "GSK Investigational Site", "city": "Concepcion del Uruguay", "state": "Entre R\u00edos", "zip": "3260", "country": "Argentina", "geoPoint": {"lat": -32.48249, "lon": -58.23722}}, {"facility": "GSK Investigational Site", "city": "Parana", "state": "Entre R\u00edos", "zip": "E3100BHK", "country": "Argentina", "geoPoint": {"lat": -31.73197, "lon": -60.5238}}, {"facility": "GSK Investigational Site", "city": "Buenos Aires", "zip": "1425", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "GSK Investigational Site", "city": "Buenos Aires", "zip": "7000", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "GSK Investigational Site", "city": "Buenos Aires", "zip": "C1425BEN", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "GSK Investigational Site", "city": "Capital Federal", "zip": "C1270AAN", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "GSK Investigational Site", "city": "Ciudad Aut\u00f3noma de Buenos Aires", "zip": "1425", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "GSK Investigational Site", "city": "Ciudad Aut\u00f3noma de Buenos Aires", "zip": "C1121ABE", "country": "Argentina", "geoPoint": {"lat": -34.61315, "lon": -58.37723}}, {"facility": "GSK Investigational Site", "city": "Lan\u00fas", "zip": "B1824KAJ", "country": "Argentina", "geoPoint": {"lat": -34.70252, "lon": -58.3955}}, {"facility": "GSK Investigational Site", "city": "San Miguel de Tucuman", "zip": "T4000IFL", "country": "Argentina", "geoPoint": {"lat": -26.82414, "lon": -65.2226}}, {"facility": "GSK Investigational Site", "city": "Westmead", "state": "New South Wales", "zip": "2145", "country": "Australia", "geoPoint": {"lat": -33.80383, "lon": 150.98768}}, {"facility": "GSK Investigational Site", "city": "Auchenflower", "state": "Queensland", "zip": "4066", "country": "Australia", "geoPoint": {"lat": -27.47443, "lon": 152.99213}}, {"facility": "GSK Investigational Site", "city": "Subiaco", "state": "Western Australia", "zip": "6008", "country": "Australia", "geoPoint": {"lat": -31.9485, "lon": 115.8268}}, {"facility": "GSK Investigational Site", "city": "Parkville", "zip": "3052", "country": "Australia", "geoPoint": {"lat": -37.78333, "lon": 144.95}}, {"facility": "GSK Investigational Site", "city": "Randwick", "zip": "2031", "country": "Australia", "geoPoint": {"lat": -33.91439, "lon": 151.24895}}, {"facility": "GSK Investigational Site", "city": "Bregenz", "zip": "A-6900", "country": "Austria", "geoPoint": {"lat": 47.50311, "lon": 9.7471}}, {"facility": "GSK Investigational Site", "city": "Feldkirch", "zip": "6800", "country": "Austria", "geoPoint": {"lat": 47.23306, "lon": 9.6}}, {"facility": "GSK Investigational Site", "city": "Wien", "zip": "1090", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"facility": "GSK Investigational Site", "city": "Antwerpen", "zip": "2018", "country": "Belgium", "geoPoint": {"lat": 51.21989, "lon": 4.40346}}, {"facility": "GSK Investigational Site", "city": "Brussels", "zip": "1090", "country": "Belgium", "geoPoint": {"lat": 50.85045, "lon": 4.34878}}, {"facility": "GSK Investigational Site", "city": "Gembloux", "zip": "5030", "country": "Belgium", "geoPoint": {"lat": 50.56149, "lon": 4.69889}}, {"facility": "GSK Investigational Site", "city": "Hamois (Natoye)", "zip": "5360", "country": "Belgium"}, {"facility": "GSK Investigational Site", "city": "Leuven", "zip": "3000", "country": "Belgium", "geoPoint": {"lat": 50.87959, "lon": 4.70093}}, {"facility": "GSK Investigational Site", "city": "Blagoevgrad", "zip": "2700", "country": "Bulgaria", "geoPoint": {"lat": 42.01667, "lon": 23.1}}, {"facility": "GSK Investigational Site", "city": "Pleven", "zip": "5800", "country": "Bulgaria", "geoPoint": {"lat": 43.41667, "lon": 24.61667}}, {"facility": "GSK Investigational Site", "city": "Plovdiv", "zip": "4002", "country": "Bulgaria", "geoPoint": {"lat": 42.15, "lon": 24.75}}, {"facility": "GSK Investigational Site", "city": "Ruse", "zip": "7000", "country": "Bulgaria", "geoPoint": {"lat": 43.85639, "lon": 25.97083}}, {"facility": "GSK Investigational Site", "city": "Ruse", "zip": "7002", "country": "Bulgaria", "geoPoint": {"lat": 43.85639, "lon": 25.97083}}, {"facility": "GSK Investigational Site", "city": "Sevlievo", "zip": "5400", "country": "Bulgaria", "geoPoint": {"lat": 43.02583, "lon": 25.11361}}, {"facility": "GSK Investigational Site", "city": "Sofia", "zip": "1431", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"facility": "GSK Investigational Site", "city": "Stara Zagora", "zip": "6000", "country": "Bulgaria", "geoPoint": {"lat": 42.43278, "lon": 25.64194}}, {"facility": "GSK Investigational Site", "city": "Varna", "zip": "9000", "country": "Bulgaria", "geoPoint": {"lat": 43.21667, "lon": 27.91667}}, {"facility": "GSK Investigational Site", "city": "Varna", "zip": "9010", "country": "Bulgaria", "geoPoint": {"lat": 43.21667, "lon": 27.91667}}, {"facility": "GSK Investigational Site", "city": "Veliko Tarnovo", "zip": "5000", "country": "Bulgaria", "geoPoint": {"lat": 43.08124, "lon": 25.62904}}, {"facility": "GSK Investigational Site", "city": "Vidin", "zip": "3700", "country": "Bulgaria", "geoPoint": {"lat": 43.99, "lon": 22.8725}}, {"facility": "GSK Investigational Site", "city": "Brampton", "state": "Ontario", "zip": "L6T3J1", "country": "Canada", "geoPoint": {"lat": 43.68341, "lon": -79.76633}}, {"facility": "GSK Investigational Site", "city": "Burlington", "state": "Ontario", "zip": "L7L 0B7", "country": "Canada", "geoPoint": {"lat": 43.38621, "lon": -79.83713}}, {"facility": "GSK Investigational Site", "city": "Oshawa", "state": "Ontario", "zip": "L1H 7K4", "country": "Canada", "geoPoint": {"lat": 43.90012, "lon": -78.84957}}, {"facility": "GSK Investigational Site", "city": "Toronto", "state": "Ontario", "zip": "M5T 3A9", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"facility": "GSK Investigational Site", "city": "Windsor", "state": "Ontario", "zip": "N8X 2G1", "country": "Canada", "geoPoint": {"lat": 42.30008, "lon": -83.01654}}, {"facility": "GSK Investigational Site", "city": "Santiago", "zip": "7560994", "country": "Chile", "geoPoint": {"lat": -33.45694, "lon": -70.64827}}, {"facility": "GSK Investigational Site", "city": "Valdivia", "zip": "5090146", "country": "Chile", "geoPoint": {"lat": -39.81422, "lon": -73.24589}}, {"facility": "GSK Investigational Site", "city": "Vi\u00f1a del Mar", "zip": "2570017", "country": "Chile", "geoPoint": {"lat": -33.02457, "lon": -71.55183}}, {"facility": "GSK Investigational Site", "city": "Medellin", "country": "Colombia", "geoPoint": {"lat": 6.25184, "lon": -75.56359}}, {"facility": "GSK Investigational Site", "city": "Cakovec", "zip": "40000", "country": "Croatia", "geoPoint": {"lat": 46.38444, "lon": 16.43389}}, {"facility": "GSK Investigational Site", "city": "Dubrovnik", "zip": "20000", "country": "Croatia", "geoPoint": {"lat": 42.64807, "lon": 18.09216}}, {"facility": "GSK Investigational Site", "city": "Jastrebarsko", "zip": "10450", "country": "Croatia", "geoPoint": {"lat": 45.66833, "lon": 15.64861}}, {"facility": "GSK Investigational Site", "city": "Rijeka", "zip": "51000", "country": "Croatia", "geoPoint": {"lat": 45.32674, "lon": 14.44239}}, {"facility": "GSK Investigational Site", "city": "Split", "zip": "21000", "country": "Croatia", "geoPoint": {"lat": 43.50891, "lon": 16.43915}}, {"facility": "GSK Investigational Site", "city": "Zagreb", "zip": "10000", "country": "Croatia", "geoPoint": {"lat": 45.81444, "lon": 15.97798}}, {"facility": "GSK Investigational Site", "city": "Brno", "zip": "615 00", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "GSK Investigational Site", "city": "Brno", "zip": "625 00", "country": "Czechia", "geoPoint": {"lat": 49.19522, "lon": 16.60796}}, {"facility": "GSK Investigational Site", "city": "Ceska Lipa", "zip": "470 01", "country": "Czechia", "geoPoint": {"lat": 50.68551, "lon": 14.53764}}, {"facility": "GSK Investigational Site", "city": "Olomouc", "zip": "775 20", "country": "Czechia", "geoPoint": {"lat": 49.59552, "lon": 17.25175}}, {"facility": "GSK Investigational Site", "city": "Praha 4", "zip": "147 00", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"facility": "GSK Investigational Site", "city": "Bruchsal", "state": "Baden-Wuerttemberg", "zip": "76646", "country": "Germany", "geoPoint": {"lat": 49.12426, "lon": 8.59804}}, {"facility": "GSK Investigational Site", "city": "Mannheim", "state": "Baden-Wuerttemberg", "zip": "68167", "country": "Germany", "geoPoint": {"lat": 49.4891, "lon": 8.46694}}, {"facility": "GSK Investigational Site", "city": "Augsburg", "state": "Bayern", "zip": "86150", "country": "Germany", "geoPoint": {"lat": 48.37154, "lon": 10.89851}}, {"facility": "GSK Investigational Site", "city": "Fuerth", "state": "Bayern", "zip": "90762", "country": "Germany", "geoPoint": {"lat": 49.47593, "lon": 10.98856}}, {"facility": "GSK Investigational Site", "city": "Hoechstadt", "state": "Bayern", "zip": "91315", "country": "Germany"}, {"facility": "GSK Investigational Site", "city": "Weissenhorn", "state": "Bayern", "zip": "89264", "country": "Germany", "geoPoint": {"lat": 48.30501, "lon": 10.16047}}, {"facility": "GSK Investigational Site", "city": "Frankfurt", "state": "Hessen", "zip": "60590", "country": "Germany", "geoPoint": {"lat": 50.11552, "lon": 8.68417}}, {"facility": "GSK Investigational Site", "city": "Bad Pyrmont", "state": "Niedersachsen", "zip": "31812", "country": "Germany", "geoPoint": {"lat": 51.98589, "lon": 9.25246}}, {"facility": "GSK Investigational Site", "city": "Bad Lippspringe", "state": "Nordrhein-Westfalen", "zip": "33175", "country": "Germany", "geoPoint": {"lat": 51.78333, "lon": 8.81683}}, {"facility": "GSK Investigational Site", "city": "Bochum", "state": "Nordrhein-Westfalen", "zip": "44791", "country": "Germany", "geoPoint": {"lat": 51.48165, "lon": 7.21648}}, {"facility": "GSK Investigational Site", "city": "Detmold", "state": "Nordrhein-Westfalen", "zip": "32756", "country": "Germany", "geoPoint": {"lat": 51.93855, "lon": 8.87318}}, {"facility": "GSK Investigational Site", "city": "Hagen", "state": "Nordrhein-Westfalen", "zip": "58089", "country": "Germany", "geoPoint": {"lat": 51.36081, "lon": 7.47168}}, {"facility": "GSK Investigational Site", "city": "Kleve-Materborn", "state": "Nordrhein-Westfalen", "zip": "47533", "country": "Germany"}, {"facility": "GSK Investigational Site", "city": "Neuss", "state": "Nordrhein-Westfalen", "zip": "41469", "country": "Germany", "geoPoint": {"lat": 51.19807, "lon": 6.68504}}, {"facility": "GSK Investigational Site", "city": "Telgte", "state": "Nordrhein-Westfalen", "zip": "48291", "country": "Germany", "geoPoint": {"lat": 51.97995, "lon": 7.78293}}, {"facility": "GSK Investigational Site", "city": "Teuchern", "state": "Sachsen-Anhalt", "zip": "6682", "country": "Germany", "geoPoint": {"lat": 51.12094, "lon": 12.0241}}, {"facility": "GSK Investigational Site", "city": "Geesthacht", "state": "Schleswig-Holstein", "zip": "21502", "country": "Germany", "geoPoint": {"lat": 53.43575, "lon": 10.3779}}, {"facility": "GSK Investigational Site", "city": "Reinfeld", "state": "Schleswig-Holstein", "zip": "23858", "country": "Germany", "geoPoint": {"lat": 53.83184, "lon": 10.49126}}, {"facility": "GSK Investigational Site", "city": "Berlin", "zip": "12157", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "GSK Investigational Site", "city": "Berlin", "zip": "13353", "country": "Germany", "geoPoint": {"lat": 52.52437, "lon": 13.41053}}, {"facility": "GSK Investigational Site", "city": "Baja", "zip": "6500", "country": "Hungary", "geoPoint": {"lat": 46.17496, "lon": 18.95639}}, {"facility": "GSK Investigational Site", "city": "Budapest", "zip": "1037", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "GSK Investigational Site", "city": "Budapest", "zip": "1089", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "GSK Investigational Site", "city": "Budapest", "zip": "1146", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"facility": "GSK Investigational Site", "city": "Miskolc", "zip": "3501", "country": "Hungary", "geoPoint": {"lat": 48.1, "lon": 20.78333}}, {"facility": "GSK Investigational Site", "city": "Nagykanizsa", "zip": "08800", "country": "Hungary", "geoPoint": {"lat": 46.45347, "lon": 16.99104}}, {"facility": "GSK Investigational Site", "city": "Rackeve", "zip": "2300", "country": "Hungary", "geoPoint": {"lat": 47.16095, "lon": 18.94478}}, {"facility": "GSK Investigational Site", "city": "Szeksz\u00e1rd", "zip": "7100", "country": "Hungary", "geoPoint": {"lat": 46.35014, "lon": 18.70905}}, {"facility": "GSK Investigational Site", "city": "T\u00f6r\u00f6kb\u00e1lint", "zip": "2045", "country": "Hungary", "geoPoint": {"lat": 47.42931, "lon": 18.91356}}, {"facility": "GSK Investigational Site", "city": "Roma", "state": "Lazio", "zip": "00157", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"facility": "GSK Investigational Site", "city": "Milano", "state": "Lombardia", "zip": "20129", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"facility": "GSK Investigational Site", "city": "Brescia", "zip": "25123", "country": "Italy", "geoPoint": {"lat": 45.53558, "lon": 10.21472}}, {"facility": "GSK Investigational Site", "city": "Messina", "zip": "98123", "country": "Italy", "geoPoint": {"lat": 38.19394, "lon": 15.55256}}, {"facility": "GSK Investigational Site", "city": "Milano", "zip": "20142", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"facility": "GSK Investigational Site", "city": "Palermo", "zip": "90146", "country": "Italy", "geoPoint": {"lat": 38.13205, "lon": 13.33561}}, {"facility": "GSK Investigational Site", "city": "Roma", "zip": "00168", "country": "Italy", "geoPoint": {"lat": 41.89193, "lon": 12.51133}}, {"facility": "GSK Investigational Site", "city": "Sesto San Giovanni", "zip": "20099", "country": "Italy", "geoPoint": {"lat": 45.53329, "lon": 9.22585}}, {"facility": "GSK Investigational Site", "city": "Cheongju-si", "zip": "361-711", "country": "Korea, Republic of", "geoPoint": {"lat": 36.63722, "lon": 127.48972}}, {"facility": "GSK Investigational Site", "city": "Gyeonggi-do", "zip": "463-712", "country": "Korea, Republic of", "geoPoint": {"lat": 37.58944, "lon": 126.76917}}, {"facility": "GSK Investigational Site", "city": "Gyeonggi-do", "zip": "471-020", "country": "Korea, Republic of", "geoPoint": {"lat": 37.58944, "lon": 126.76917}}, {"facility": "GSK Investigational Site", "city": "Gyeonggi-do", "zip": "480-717", "country": "Korea, Republic of", "geoPoint": {"lat": 37.58944, "lon": 126.76917}}, {"facility": "GSK Investigational Site", "city": "Incheon", "zip": "400-711", "country": "Korea, Republic of", "geoPoint": {"lat": 37.45646, "lon": 126.70515}}, {"facility": "GSK Investigational Site", "city": "Pusan", "zip": "612030", "country": "Korea, Republic of", "geoPoint": {"lat": 35.10278, "lon": 129.04028}}, {"facility": "GSK Investigational Site", "city": "Seoul", "zip": "110-744", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "GSK Investigational Site", "city": "Seoul", "zip": "120-752", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "GSK Investigational Site", "city": "Seoul", "zip": "130-702", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "GSK Investigational Site", "city": "Seoul", "zip": "137-701", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "GSK Investigational Site", "city": "Seoul", "zip": "143-729", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"facility": "GSK Investigational Site", "city": "Riga", "zip": "1011", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "GSK Investigational Site", "city": "Riga", "zip": "1063", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "GSK Investigational Site", "city": "Riga", "zip": "LV 1003", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "GSK Investigational Site", "city": "Riga", "zip": "LV 1004", "country": "Latvia", "geoPoint": {"lat": 56.946, "lon": 24.10589}}, {"facility": "GSK Investigational Site", "city": "Tukums", "zip": "3101", "country": "Latvia", "geoPoint": {"lat": 56.96694, "lon": 23.15528}}, {"facility": "GSK Investigational Site", "city": "Kaunas", "zip": "LT-49449", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "GSK Investigational Site", "city": "Kaunas", "zip": "LT-50009", "country": "Lithuania", "geoPoint": {"lat": 54.90272, "lon": 23.90961}}, {"facility": "GSK Investigational Site", "city": "Utena", "zip": "LT-28151", "country": "Lithuania", "geoPoint": {"lat": 55.49765, "lon": 25.59918}}, {"facility": "GSK Investigational Site", "city": "Vilnius", "zip": "LT-04338", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"facility": "GSK Investigational Site", "city": "Vilnius", "zip": "LT-08406", "country": "Lithuania", "geoPoint": {"lat": 54.68916, "lon": 25.2798}}, {"facility": "GSK Investigational Site", "city": "Ipoh", "zip": "32040", "country": "Malaysia", "geoPoint": {"lat": 4.5841, "lon": 101.0829}}, {"facility": "GSK Investigational Site", "city": "Kuala Lumpur", "zip": "59100", "country": "Malaysia", "geoPoint": {"lat": 3.1412, "lon": 101.68653}}, {"facility": "GSK Investigational Site", "city": "Kuching", "zip": "93586", "country": "Malaysia", "geoPoint": {"lat": 1.54999, "lon": 110.33333}}, {"facility": "GSK Investigational Site", "city": "Seremban, Negeri Sembilan", "zip": "70300", "country": "Malaysia"}, {"facility": "GSK Investigational Site", "city": "Sibu", "zip": "96000", "country": "Malaysia", "geoPoint": {"lat": 2.29998, "lon": 111.81667}}, {"facility": "GSK Investigational Site", "city": "Sungai Buloh", "zip": "47000", "country": "Malaysia", "geoPoint": {"lat": 3.2, "lon": 101.58333}}, {"facility": "GSK Investigational Site", "city": "Guadalajara", "state": "Jalisco", "zip": "44100", "country": "Mexico", "geoPoint": {"lat": 20.66682, "lon": -103.39182}}, {"facility": "GSK Investigational Site", "city": "Monterrey", "state": "Nuevo Le\u00f3n", "zip": "64710", "country": "Mexico", "geoPoint": {"lat": 25.67507, "lon": -100.31847}}, {"facility": "GSK Investigational Site", "city": "Chihuahua", "zip": "31020", "country": "Mexico", "geoPoint": {"lat": 28.63528, "lon": -106.08889}}, {"facility": "GSK Investigational Site", "city": "Huixquilucan", "zip": "52763", "country": "Mexico", "geoPoint": {"lat": 19.35985, "lon": -99.35016}}, {"facility": "GSK Investigational Site", "city": "Monterrey", "zip": "64718", "country": "Mexico", "geoPoint": {"lat": 25.67507, "lon": -100.31847}}, {"facility": "GSK Investigational Site", "city": "Miraflores", "state": "Lima", "zip": "18", "country": "Peru"}, {"facility": "GSK Investigational Site", "city": "San Martin de Porres", "state": "Lima", "zip": "Lima 31", "country": "Peru"}, {"facility": "GSK Investigational Site", "city": "Santiago de Surco", "state": "Lima", "zip": "Lima 33", "country": "Peru", "geoPoint": {"lat": -12.13588, "lon": -77.00742}}, {"facility": "GSK Investigational Site", "city": "Lima", "zip": "Lima 18", "country": "Peru", "geoPoint": {"lat": -12.04318, "lon": -77.02824}}, {"facility": "GSK Investigational Site", "city": "Lima", "zip": "Lima 1", "country": "Peru", "geoPoint": {"lat": -12.04318, "lon": -77.02824}}, {"facility": "GSK Investigational Site", "city": "Lima", "zip": "Lima 27", "country": "Peru", "geoPoint": {"lat": -12.04318, "lon": -77.02824}}, {"facility": "GSK Investigational Site", "city": "San Borja", "zip": "L36", "country": "Peru", "geoPoint": {"lat": -12.09841, "lon": -77.01107}}, {"facility": "GSK Investigational Site", "city": "Dasmari\u00f1as, Cavite", "zip": "4114", "country": "Philippines"}, {"facility": "GSK Investigational Site", "city": "Davao", "zip": "8000", "country": "Philippines", "geoPoint": {"lat": 7.07306, "lon": 125.61278}}, {"facility": "GSK Investigational Site", "city": "Pulilan", "zip": "3005", "country": "Philippines", "geoPoint": {"lat": 14.90167, "lon": 120.84917}}, {"facility": "GSK Investigational Site", "city": "Quezon City", "zip": "1100", "country": "Philippines", "geoPoint": {"lat": 14.6488, "lon": 121.0509}}, {"facility": "GSK Investigational Site", "city": "Quezon City", "zip": "1108", "country": "Philippines", "geoPoint": {"lat": 14.6488, "lon": 121.0509}}, {"facility": "GSK Investigational Site", "city": "Bialystok", "zip": "15-430", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "GSK Investigational Site", "city": "Bialystok", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"facility": "GSK Investigational Site", "city": "Cieszyn", "zip": "43-400", "country": "Poland", "geoPoint": {"lat": 49.75133, "lon": 18.63213}}, {"facility": "GSK Investigational Site", "city": "D\u0119bica", "zip": "39 - 200", "country": "Poland", "geoPoint": {"lat": 50.05146, "lon": 21.41141}}, {"facility": "GSK Investigational Site", "city": "Gdanska", "zip": "80-433", "country": "Poland"}, {"facility": "GSK Investigational Site", "city": "Gdansk", "zip": "80-308", "country": "Poland", "geoPoint": {"lat": 54.35205, "lon": 18.64637}}, {"facility": "GSK Investigational Site", "city": "Gdansk", "zip": "80-462", "country": "Poland", "geoPoint": {"lat": 54.35205, "lon": 18.64637}}, {"facility": "GSK Investigational Site", "city": "Jelenia Gora", "zip": "58-500", "country": "Poland", "geoPoint": {"lat": 50.89973, "lon": 15.72899}}, {"facility": "GSK Investigational Site", "city": "Karpacz", "zip": "58-540", "country": "Poland", "geoPoint": {"lat": 50.77669, "lon": 15.75594}}, {"facility": "GSK Investigational Site", "city": "Koszalin", "zip": "75-729", "country": "Poland", "geoPoint": {"lat": 54.19438, "lon": 16.17222}}, {"facility": "GSK Investigational Site", "city": "Krakow", "zip": "31-023", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "GSK Investigational Site", "city": "Krakow", "zip": "31-503", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"facility": "GSK Investigational Site", "city": "Lodz", "zip": "90-553", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "GSK Investigational Site", "city": "Lodz", "zip": "93-513", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"facility": "GSK Investigational Site", "city": "Lubin", "zip": "59-300", "country": "Poland", "geoPoint": {"lat": 51.40089, "lon": 16.20149}}, {"facility": "GSK Investigational Site", "city": "Lublin", "zip": "20-093", "country": "Poland", "geoPoint": {"lat": 51.25, "lon": 22.56667}}, {"facility": "GSK Investigational Site", "city": "Lublin", "zip": "20-552", "country": "Poland", "geoPoint": {"lat": 51.25, "lon": 22.56667}}, {"facility": "GSK Investigational Site", "city": "Poznan", "zip": "60-214", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"facility": "GSK Investigational Site", "city": "Rzeszow", "zip": "35-241", "country": "Poland", "geoPoint": {"lat": 50.04132, "lon": 21.99901}}, {"facility": "GSK Investigational Site", "city": "Sandomierz", "zip": "27-600", "country": "Poland", "geoPoint": {"lat": 50.68265, "lon": 21.74898}}, {"facility": "GSK Investigational Site", "city": "Skar\u017cysko-Kamienna", "zip": "26-110", "country": "Poland", "geoPoint": {"lat": 51.11311, "lon": 20.87162}}, {"facility": "GSK Investigational Site", "city": "Skierniewice", "zip": "96-100", "country": "Poland", "geoPoint": {"lat": 51.95485, "lon": 20.15837}}, {"facility": "GSK Investigational Site", "city": "Szczecin", "zip": "70-382", "country": "Poland", "geoPoint": {"lat": 53.42894, "lon": 14.55302}}, {"facility": "GSK Investigational Site", "city": "Szczecin", "zip": "70-780", "country": "Poland", "geoPoint": {"lat": 53.42894, "lon": 14.55302}}, {"facility": "GSK Investigational Site", "city": "Tarnow", "zip": "33-100", "country": "Poland", "geoPoint": {"lat": 50.01381, "lon": 20.98698}}, {"facility": "GSK Investigational Site", "city": "Warszawa", "zip": "01-157", "country": "Poland", "geoPoint": {"lat": 52.22977, "lon": 21.01178}}, {"facility": "GSK Investigational Site", "city": "Wroclaw", "zip": "50-445", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"facility": "GSK Investigational Site", "city": "Wroclaw", "zip": "53-301", "country": "Poland", "geoPoint": {"lat": 51.1, "lon": 17.03333}}, {"facility": "GSK Investigational Site", "city": "Zabrze", "zip": "41 - 800", "country": "Poland", "geoPoint": {"lat": 50.32492, "lon": 18.78576}}, {"facility": "GSK Investigational Site", "city": "Zabrze", "zip": "41-800", "country": "Poland", "geoPoint": {"lat": 50.32492, "lon": 18.78576}}, {"facility": "GSK Investigational Site", "city": "Bucharest", "zip": "20395", "country": "Romania", "geoPoint": {"lat": 44.43225, "lon": 26.10626}}, {"facility": "GSK Investigational Site", "city": "Sibiu", "zip": "550166", "country": "Romania", "geoPoint": {"lat": 45.8, "lon": 24.15}}, {"facility": "GSK Investigational Site", "city": "Moscow", "zip": "119435", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "GSK Investigational Site", "city": "Moscow", "zip": "119991", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "GSK Investigational Site", "city": "Moscow", "zip": "125412", "country": "Russian Federation", "geoPoint": {"lat": 55.75222, "lon": 37.61556}}, {"facility": "GSK Investigational Site", "city": "Nizhniy Novgorod", "zip": "603005", "country": "Russian Federation", "geoPoint": {"lat": 56.32867, "lon": 44.00205}}, {"facility": "GSK Investigational Site", "city": "Novosibirsk", "zip": "630099", "country": "Russian Federation", "geoPoint": {"lat": 55.0415, "lon": 82.9346}}, {"facility": "GSK Investigational Site", "city": "Saint Petersburg", "zip": "192212", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "GSK Investigational Site", "city": "Saint Petersburg", "zip": "196084", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "GSK Investigational Site", "city": "Saint Petersburg", "zip": "196657", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "GSK Investigational Site", "city": "Saratov", "zip": "410028", "country": "Russian Federation", "geoPoint": {"lat": 51.54056, "lon": 46.00861}}, {"facility": "GSK Investigational Site", "city": "St'Petersburg", "zip": "191144", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "GSK Investigational Site", "city": "St. Petersburg", "zip": "194100", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "GSK Investigational Site", "city": "St.Petersburg", "zip": "194100", "country": "Russian Federation", "geoPoint": {"lat": 59.93863, "lon": 30.31413}}, {"facility": "GSK Investigational Site", "city": "Tomsk", "zip": "634 050", "country": "Russian Federation", "geoPoint": {"lat": 56.49771, "lon": 84.97437}}, {"facility": "GSK Investigational Site", "city": "Voronezh", "zip": "394036", "country": "Russian Federation", "geoPoint": {"lat": 51.67204, "lon": 39.1843}}, {"facility": "GSK Investigational Site", "city": "Yaroslavl", "zip": "150003", "country": "Russian Federation", "geoPoint": {"lat": 57.62987, "lon": 39.87368}}, {"facility": "GSK Investigational Site", "city": "Belgrade", "zip": "11000", "country": "Serbia", "geoPoint": {"lat": 44.80401, "lon": 20.46513}}, {"facility": "GSK Investigational Site", "city": "Cacak", "zip": "32000", "country": "Serbia", "geoPoint": {"lat": 43.89139, "lon": 20.34972}}, {"facility": "GSK Investigational Site", "city": "Nis", "zip": "18000", "country": "Serbia", "geoPoint": {"lat": 43.32472, "lon": 21.90333}}, {"facility": "GSK Investigational Site", "city": "Novi Sad", "zip": "21 000", "country": "Serbia", "geoPoint": {"lat": 45.25167, "lon": 19.83694}}, {"facility": "GSK Investigational Site", "city": "Uzice", "zip": "31000", "country": "Serbia", "geoPoint": {"lat": 43.85861, "lon": 19.84878}}, {"facility": "GSK Investigational Site", "city": "Martin", "zip": "036 59", "country": "Slovakia", "geoPoint": {"lat": 49.06651, "lon": 18.92399}}, {"facility": "GSK Investigational Site", "city": "Nitra", "zip": "949 01", "country": "Slovakia", "geoPoint": {"lat": 48.30763, "lon": 18.08453}}, {"facility": "GSK Investigational Site", "city": "Trnava", "zip": "917 01", "country": "Slovakia", "geoPoint": {"lat": 48.37741, "lon": 17.58723}}, {"facility": "GSK Investigational Site", "city": "Welkom", "state": "Free State", "zip": "9460", "country": "South Africa", "geoPoint": {"lat": -27.97742, "lon": 26.73506}}, {"facility": "GSK Investigational Site", "city": "Benoni", "state": "Gauteng", "zip": "1501", "country": "South Africa", "geoPoint": {"lat": -26.18848, "lon": 28.32078}}, {"facility": "GSK Investigational Site", "city": "Krugersdorp", "state": "Gauteng", "zip": "1752", "country": "South Africa", "geoPoint": {"lat": -26.08577, "lon": 27.77515}}, {"facility": "GSK Investigational Site", "city": "Pretoria", "state": "Gauteng", "zip": "0132", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "GSK Investigational Site", "city": "Benoni", "zip": "1501", "country": "South Africa", "geoPoint": {"lat": -26.18848, "lon": 28.32078}}, {"facility": "GSK Investigational Site", "city": "Cape Town", "zip": "7441", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "GSK Investigational Site", "city": "Cape Town", "zip": "7500", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "GSK Investigational Site", "city": "Cape Town", "zip": "7572", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "GSK Investigational Site", "city": "Cape Town", "zip": "7700", "country": "South Africa", "geoPoint": {"lat": -33.92584, "lon": 18.42322}}, {"facility": "GSK Investigational Site", "city": "Claremont", "zip": "7708", "country": "South Africa", "geoPoint": {"lat": -33.98056, "lon": 18.46528}}, {"facility": "GSK Investigational Site", "city": "Durban", "zip": "4001", "country": "South Africa", "geoPoint": {"lat": -29.8579, "lon": 31.0292}}, {"facility": "GSK Investigational Site", "city": "Middelburg", "zip": "1501", "country": "South Africa", "geoPoint": {"lat": -25.77507, "lon": 29.46482}}, {"facility": "GSK Investigational Site", "city": "Paarl", "zip": "7646", "country": "South Africa", "geoPoint": {"lat": -33.73378, "lon": 18.97523}}, {"facility": "GSK Investigational Site", "city": "Pretoria", "zip": "0001", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "GSK Investigational Site", "city": "Pretoria", "zip": "0002", "country": "South Africa", "geoPoint": {"lat": -25.74486, "lon": 28.18783}}, {"facility": "GSK Investigational Site", "city": "Thabazimbi", "zip": "0380", "country": "South Africa", "geoPoint": {"lat": -24.59165, "lon": 27.41155}}, {"facility": "GSK Investigational Site", "city": "Barcelona", "zip": "08022", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"facility": "GSK Investigational Site", "city": "Burgos", "zip": "09005", "country": "Spain", "geoPoint": {"lat": 42.34106, "lon": -3.70184}}, {"facility": "GSK Investigational Site", "city": "Madrid", "zip": "28041", "country": "Spain", "geoPoint": {"lat": 40.4165, "lon": -3.70256}}, {"facility": "GSK Investigational Site", "city": "Pozuelo De Alarc\u00f3n/Madrid", "zip": "28223", "country": "Spain"}, {"facility": "GSK Investigational Site", "city": "Sabadell (Barcelona)", "zip": "8208", "country": "Spain"}, {"facility": "GSK Investigational Site", "city": "Valencia", "zip": "46026", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}, {"facility": "GSK Investigational Site", "city": "Changhua", "zip": "500", "country": "Taiwan", "geoPoint": {"lat": 24.07327, "lon": 120.56276}}, {"facility": "GSK Investigational Site", "city": "Kaohsiung", "zip": "807", "country": "Taiwan", "geoPoint": {"lat": 22.61626, "lon": 120.31333}}, {"facility": "GSK Investigational Site", "city": "Kaohsiung", "zip": "813", "country": "Taiwan", "geoPoint": {"lat": 22.61626, "lon": 120.31333}}, {"facility": "GSK Investigational Site", "city": "Taichung", "zip": "402", "country": "Taiwan", "geoPoint": {"lat": 24.1469, "lon": 120.6839}}, {"facility": "GSK Investigational Site", "city": "Taichung", "zip": "40447", "country": "Taiwan", "geoPoint": {"lat": 24.1469, "lon": 120.6839}}, {"facility": "GSK Investigational Site", "city": "Taipei", "zip": "100", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"facility": "GSK Investigational Site", "city": "Taipei", "zip": "11031", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"facility": "GSK Investigational Site", "city": "Taoyuan", "zip": "333", "country": "Taiwan", "geoPoint": {"lat": 24.95233, "lon": 121.20193}}, {"facility": "GSK Investigational Site", "city": "Bangkoknoi", "zip": "10700", "country": "Thailand", "geoPoint": {"lat": 13.76266, "lon": 100.47798}}, {"facility": "GSK Investigational Site", "city": "Bangkok", "zip": "10330", "country": "Thailand", "geoPoint": {"lat": 13.75398, "lon": 100.50144}}, {"facility": "GSK Investigational Site", "city": "Bangkok", "country": "Thailand", "geoPoint": {"lat": 13.75398, "lon": 100.50144}}, {"facility": "GSK Investigational Site", "city": "Khon Kaen", "zip": "40002", "country": "Thailand", "geoPoint": {"lat": 16.44671, "lon": 102.833}}, {"facility": "GSK Investigational Site", "city": "Pathumthani", "zip": "12120", "country": "Thailand", "geoPoint": {"lat": 14.01346, "lon": 100.53049}}, {"facility": "GSK Investigational Site", "city": "Phitsanulok", "zip": "65000", "country": "Thailand", "geoPoint": {"lat": 16.82481, "lon": 100.25858}}, {"facility": "GSK Investigational Site", "city": "Ratchatewi", "zip": "10400", "country": "Thailand"}, {"facility": "GSK Investigational Site", "city": "Dnipropetrovsk", "zip": "49100", "country": "Ukraine", "geoPoint": {"lat": 48.4593, "lon": 35.03864}}, {"facility": "GSK Investigational Site", "city": "Dnipropetrovsk", "zip": "49101", "country": "Ukraine", "geoPoint": {"lat": 48.4593, "lon": 35.03864}}, {"facility": "GSK Investigational Site", "city": "Kharkiv", "zip": "61050", "country": "Ukraine", "geoPoint": {"lat": 49.98081, "lon": 36.25272}}, {"facility": "GSK Investigational Site", "city": "Kharkiv", "zip": "61093", "country": "Ukraine", "geoPoint": {"lat": 49.98081, "lon": 36.25272}}, {"facility": "GSK Investigational Site", "city": "Kryvyi Rih", "zip": "50082", "country": "Ukraine", "geoPoint": {"lat": 47.90966, "lon": 33.38044}}, {"facility": "GSK Investigational Site", "city": "Kyiv", "zip": "4050", "country": "Ukraine", "geoPoint": {"lat": 50.45466, "lon": 30.5238}}, {"facility": "GSK Investigational Site", "city": "Kyiv", "country": "Ukraine", "geoPoint": {"lat": 50.45466, "lon": 30.5238}}, {"facility": "GSK Investigational Site", "city": "Lviv", "zip": "79059", "country": "Ukraine", "geoPoint": {"lat": 49.83826, "lon": 24.02324}}, {"facility": "GSK Investigational Site", "city": "Odesa", "zip": "65031", "country": "Ukraine", "geoPoint": {"lat": 46.47747, "lon": 30.73262}}, {"facility": "GSK Investigational Site", "city": "Odesa", "zip": "65038", "country": "Ukraine", "geoPoint": {"lat": 46.47747, "lon": 30.73262}}, {"facility": "GSK Investigational Site", "city": "Poltava", "zip": "36011", "country": "Ukraine", "geoPoint": {"lat": 49.59373, "lon": 34.54073}}, {"facility": "GSK Investigational Site", "city": "Simferopol", "zip": "95006", "country": "Ukraine", "geoPoint": {"lat": 44.95719, "lon": 34.11079}}, {"facility": "GSK Investigational Site", "city": "Sumy", "zip": "40031", "country": "Ukraine", "geoPoint": {"lat": 50.9216, "lon": 34.80029}}, {"facility": "GSK Investigational Site", "city": "Uzhhorod", "zip": "88009", "country": "Ukraine", "geoPoint": {"lat": 48.61667, "lon": 22.3}}, {"facility": "GSK Investigational Site", "city": "Zaporizhia", "zip": "69063", "country": "Ukraine", "geoPoint": {"lat": 47.82289, "lon": 35.19031}}, {"facility": "GSK Investigational Site", "city": "Chesterfield", "state": "Derbyshire", "zip": "S40 4TF", "country": "United Kingdom", "geoPoint": {"lat": 53.25, "lon": -1.41667}}, {"facility": "GSK Investigational Site", "city": "Cardiff", "state": "Glamorgan", "zip": "CF5 4AE", "country": "United Kingdom", "geoPoint": {"lat": 51.48, "lon": -3.18}}, {"facility": "GSK Investigational Site", "city": "Newcastle Upon Tyne", "state": "Northumberland", "zip": "NE1 4LP", "country": "United Kingdom", "geoPoint": {"lat": 54.97328, "lon": -1.61396}}, {"facility": "GSK Investigational Site", "city": "Bath", "state": "Somerset", "zip": "BA2 1NH", "country": "United Kingdom", "geoPoint": {"lat": 51.3751, "lon": -2.36172}}, {"facility": "GSK Investigational Site", "city": "Brighton", "state": "Sussex East", "zip": "BN2 5BE", "country": "United Kingdom", "geoPoint": {"lat": 50.82838, "lon": -0.13947}}, {"facility": "GSK Investigational Site", "city": "Atherstone", "state": "Warwickshire", "zip": "CV9 1EU", "country": "United Kingdom", "geoPoint": {"lat": 52.57536, "lon": -1.54693}}, {"facility": "GSK Investigational Site", "city": "Barry", "zip": "CF63 4AR", "country": "United Kingdom", "geoPoint": {"lat": 51.39979, "lon": -3.2838}}, {"facility": "GSK Investigational Site", "city": "Bexhill-on-Sea", "zip": "TN40 1JJ", "country": "United Kingdom", "geoPoint": {"lat": 50.85023, "lon": 0.47095}}, {"facility": "GSK Investigational Site", "city": "Doncaster", "zip": "DN9 2HY", "country": "United Kingdom", "geoPoint": {"lat": 53.52285, "lon": -1.13116}}, {"facility": "GSK Investigational Site", "city": "Glasgow", "zip": "G3 8SJ", "country": "United Kingdom", "geoPoint": {"lat": 55.86515, "lon": -4.25763}}, {"facility": "GSK Investigational Site", "city": "Kent", "zip": "CT5 3QU", "country": "United Kingdom"}, {"facility": "GSK Investigational Site", "city": "Leicester", "zip": "LE1 5WW", "country": "United Kingdom", "geoPoint": {"lat": 52.6386, "lon": -1.13169}}, {"facility": "GSK Investigational Site", "city": "Macclesfield", "zip": "SK10 3BL", "country": "United Kingdom", "geoPoint": {"lat": 53.26023, "lon": -2.12564}}, {"facility": "GSK Investigational Site", "city": "Merseyside", "zip": "CH41 0DD", "country": "United Kingdom"}, {"facility": "GSK Investigational Site", "city": "Penzance", "zip": "TK19 7HX", "country": "United Kingdom", "geoPoint": {"lat": 50.11861, "lon": -5.53715}}, {"facility": "GSK Investigational Site", "city": "Peterborough", "zip": "PE8 6PL", "country": "United Kingdom", "geoPoint": {"lat": 52.57364, "lon": -0.24777}}, {"facility": "GSK Investigational Site", "city": "Stockton on Tees", "zip": "TS19 8PE", "country": "United Kingdom", "geoPoint": {"lat": 54.56848, "lon": -1.3187}}, {"facility": "GSK Investigational Site", "city": "Stoke on Trent", "zip": "ST4 6QG", "country": "United Kingdom", "geoPoint": {"lat": 53.00415, "lon": -2.18538}}, {"facility": "GSK Investigational Site", "city": "Surrey", "zip": "RH1 5RH", "country": "United Kingdom"}]}, "referencesModule": {"references": [{"pmid": "32966707", "type": "DERIVED", "citation": "Lee LA, Pedersen S, Pascoe SJ, Szefler SJ, Lenney W. No dose effect observed with chronic fluticasone propionate on growth velocity in children. Pediatr Allergy Immunol. 2021 Feb;32(2):377-381. doi: 10.1111/pai.13378. Epub 2020 Oct 26. No abstract available."}, {"pmid": "27579634", "type": "DERIVED", "citation": "Stempel DA, Szefler SJ, Pedersen S, Zeiger RS, Yeakey AM, Lee LA, Liu AH, Mitchell H, Kral KM, Raphiou IH, Prillaman BA, Buaron KS, Yun Kirby S, Pascoe SJ; VESTRI Investigators. Safety of Adding Salmeterol to Fluticasone Propionate in Children with Asthma. N Engl J Med. 2016 Sep 1;375(9):840-9. doi: 10.1056/NEJMoa1606356."}], "seeAlsoLinks": [{"label": "Researchers can use this site to request access to anonymised patient level data and/or supporting documents from clinical studies to conduct further research.", "url": "https://www.clinicalstudydatarequest.com"}], "availIpds": [{"id": "115358", "type": "Individual Participant Data Set", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "115358", "type": "Statistical Analysis Plan", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "115358", "type": "Study Protocol", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "115358", "type": "Dataset Specification", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "115358", "type": "Clinical Study Report", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "115358", "type": "Informed Consent Form", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}, {"id": "115358", "type": "Annotated Case Report Form", "url": "https://www.clinicalstudydatarequest.com", "comment": "For additional information about this study please refer to the GSK Clinical Study Register"}]}, "ipdSharingStatementModule": {"ipdSharing": "YES", "description": "Patient-level data for this study will be made available through www.clinicalstudydatarequest.com following the timelines and process described on this site."}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Participants aged between 4 to 11 years having asthma, defined by the regional asthma guidelines for at least 6 months, having history of at least one occurrence of treatment with systemic corticosteroid and with no change in asthma therapy for the last 4 weeks from first visit were enrolled for the study.", "recruitmentDetails": "A total of 6250 participants were enrolled and randomized to study treatments; total 6208 participants took at least one dose of study drug.", "groups": [{"id": "FG000", "title": "Fluticasone Propionate/Salmeterol Combination (FSC)", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "FG001", "title": "Fluticasone Propionate (FP)", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "3107"}, {"groupId": "FG001", "numSubjects": "3101"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2724"}, {"groupId": "FG001", "numSubjects": "2751"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "383"}, {"groupId": "FG001", "numSubjects": "350"}]}], "dropWithdraws": [{"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "245"}, {"groupId": "FG001", "numSubjects": "226"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "24"}, {"groupId": "FG001", "numSubjects": "23"}]}, {"type": "Asthma Exacerbation", "reasons": [{"groupId": "FG000", "numSubjects": "34"}, {"groupId": "FG001", "numSubjects": "35"}]}, {"type": "Lack of Efficacy", "reasons": [{"groupId": "FG000", "numSubjects": "5"}, {"groupId": "FG001", "numSubjects": "6"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "68"}, {"groupId": "FG001", "numSubjects": "53"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "7"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "BG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "3107"}, {"groupId": "BG001", "value": "3101"}, {"groupId": "BG002", "value": "6208"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "7.6", "spread": "2.21"}, {"groupId": "BG001", "value": "7.6", "spread": "2.20"}, {"groupId": "BG002", "value": "7.6", "spread": "2.20"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "1187"}, {"groupId": "BG001", "value": "1227"}, {"groupId": "BG002", "value": "2414"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "1920"}, {"groupId": "BG001", "value": "1874"}, {"groupId": "BG002", "value": "3794"}]}]}]}, {"title": "Race/Ethnicity, Customized", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "African American / African Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "539"}, {"groupId": "BG001", "value": "511"}, {"groupId": "BG002", "value": "1050"}]}]}, {"title": "American Indian or Alaskan Native", "categories": [{"measurements": [{"groupId": "BG000", "value": "144"}, {"groupId": "BG001", "value": "118"}, {"groupId": "BG002", "value": "262"}]}]}, {"title": "Asian - Central / South Asian Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "30"}, {"groupId": "BG001", "value": "37"}, {"groupId": "BG002", "value": "67"}]}]}, {"title": "Asian - East Asian Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "96"}, {"groupId": "BG001", "value": "112"}, {"groupId": "BG002", "value": "208"}]}]}, {"title": "Japanese Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}]}, {"title": "Asian - South East Asian Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "122"}, {"groupId": "BG001", "value": "108"}, {"groupId": "BG002", "value": "230"}]}]}, {"title": "Native Hawaiian or Other Pacific Islander", "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "6"}]}]}, {"title": "White - Arabic / North African Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "28"}]}]}, {"title": "White - White / Caucasian / European Heritage", "categories": [{"measurements": [{"groupId": "BG000", "value": "1985"}, {"groupId": "BG001", "value": "2017"}, {"groupId": "BG002", "value": "4002"}]}]}, {"title": "Mixed Race", "categories": [{"measurements": [{"groupId": "BG000", "value": "167"}, {"groupId": "BG001", "value": "180"}, {"groupId": "BG002", "value": "347"}]}]}, {"title": "Missing", "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "2"}, {"groupId": "BG002", "value": "7"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants Experiencing an Event in the Composite Safety Endpoint of Serious Asthma Outcomes ( Asthma-related Hospitalization, Asthma-related Endotracheal Intubation, or Asthma-related Death)", "description": "Composite endpoint was defined as clinically relevant endpoint that is constructed from combinations of other clinically relevant endpoints of serious asthma outcomes (i.e., asthma-related hospitalization, asthma-related endotracheal intubation, or asthma-related death). Hospitalization was defined as an inpatient stay or a \\>=24-hour stay in an observation area in an emergency department or other equivalent facility. Time to first event in the composite endpoint of serious asthma-related outcomes over the 6-month study treatment period was analyzed using a Cox proportional hazards regression model. An estimate of absolute risk difference and its corresponding 95% confidence interval (CI) were also included. The Intent-to-Treat (ITT) Population included all participants randomized to study drug and who took study treatment.", "populationDescription": "ITT Population", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Day 1 up to 6 months", "groups": [{"id": "OG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "OG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3107"}, {"groupId": "OG001", "value": "3101"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27"}, {"groupId": "OG001", "value": "21"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "NON_INFERIORITY_OR_EQUIVALENCE", "nonInferiorityComment": "The non-inferiority comparison was statistically significant if the upper bound of the two-sided 95% CI falls below 2.675, the non-inferiority margin, and the non-inferiority test one-sided p-value \\<0.025.", "pValue": "0.006", "statisticalMethod": "Regression, Cox", "paramType": "Hazard Ratio (HR)", "paramValue": "1.285", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.726", "ciUpperLimit": "2.272", "estimateComment": "Estimated for Hazard ratio"}, {"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "paramType": "Risk Difference (RD)", "paramValue": "0.0019", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.0024", "ciUpperLimit": "0.0063", "estimateComment": "Estimated for Absolute risk difference"}]}, {"type": "PRIMARY", "title": "Number of Participants With at Least One Asthma Exacerbation Over the 6-month Study Treatment Period", "description": "Number of participants with asthma exacerbation over the 6-month study treatment period are presented. Participants from mITT population with screening childhood asthma control test (C-ACT) scores of 20 or higher, one exacerbation in the previous year, and either low-dose inhaled corticosteroid (ICS) + one or more adjunctive therapy or medium-dose ICS monotherapy or medium-dose ICS and one or more adjunctive therapy as prior asthma therapy were included for this endpoint. Time to first exacerbation analyzed using a cox proportional hazards regression model. The number of asthma exacerbations were compared between treatments using a negative binomial regression model. The modified Intent-to-Treat (mITT) Population consisted of the ITT participants with a different data cut-off for supportive analyses of the primary composite safety endpoint.", "populationDescription": "mITT Population", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Day 1 up to 6 months", "groups": [{"id": "OG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "OG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3107"}, {"groupId": "OG001", "value": "3101"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "265"}, {"groupId": "OG001", "value": "309"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY_OR_OTHER", "paramType": "Hazard Ratio (HR)", "paramValue": "0.859", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "0.729", "ciUpperLimit": "1.012", "estimateComment": "Estimated for Hazard ratio"}]}, {"type": "SECONDARY", "title": "Number of Participants Experiencing Asthma-related Deaths Over the 6-month Study Treatment Period.", "description": "Number of participants experiencing asthma-related death over the 6-month study treatment period are presented.", "populationDescription": "ITT Population", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Day 1 up to 6 months", "groups": [{"id": "OG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "OG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3107"}, {"groupId": "OG001", "value": "3101"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants Experiencing Asthma-related Endotracheal Intubations Over the 6-month Study Treatment Period", "description": "Intubation is defined as endotracheal intubation with ventilation (mechanical or by hand). The number of participants experiencing asthma-related endotracheal intubations over the 6-month study treatment period are presented.", "populationDescription": "ITT Population", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Day 1 up to 6 months", "groups": [{"id": "OG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "OG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3107"}, {"groupId": "OG001", "value": "3101"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants Experiencing Asthma-related Hospitalizations Over the 6-month Study Treatment Period", "description": "Hospitalization is defined as a \\>=24-hour stay as an inpatient or in an observation ward. The number of participants experiencing asthma-related hospitalizations over the 6-month study treatment period are presented.", "populationDescription": "ITT Population", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Day 1 up to 6 months", "groups": [{"id": "OG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "OG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3107"}, {"groupId": "OG001", "value": "3101"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "27"}, {"groupId": "OG001", "value": "21"}]}]}]}, {"type": "SECONDARY", "title": "Number of Participants Withdrawn From Study Treatment Due to Asthma Exacerbation Over the 6-month Study Treatment Period", "description": "An exacerbation is defined as deterioration of asthma requiring the use of systemic corticosteroids (tablets, suspension, or injection) for at least 3 days (up to 10 days) or a single depot corticosteroid injection. Number of participants experiencing at least one exacerbation from mITT population were included for this endpoint. The number of participants withdrawn from study treatment due to asthma exacerbation over the 6-month study treatment period are presented.", "populationDescription": "mITT Population", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "From Day 1 up to 6 months", "groups": [{"id": "OG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "OG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "265"}, {"groupId": "OG001", "value": "309"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "33"}, {"groupId": "OG001", "value": "35"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Rescue-free Days Over the 6-month Study Treatment Period", "description": "Rescue-free days were days without use of rescue albuterol/salbutamol (other than pre-exercise treatment) over the 6-month study treatment period. The mean percentages of rescue-free days over the months 1-6 (defined as treatment days 2-182) are summarized. Number of participants over treatment days 2-182 from mITT Population were included for this endpoint.", "populationDescription": "mITT Population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Percentage of rescue-free days", "timeFrame": "From Day 1 up to 6 months", "groups": [{"id": "OG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "OG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "3049"}, {"groupId": "OG001", "value": "3036"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "83.0", "spread": "0.50"}, {"groupId": "OG001", "value": "81.9", "spread": "0.52"}]}]}]}, {"type": "SECONDARY", "title": "Percentage of Asthma Control Days Over the 6-month Study Treatment Period", "description": "An asthma control day is one on which rescue albuterol/salbutamol use was recorded as 0, no night time awakenings were recorded, no asthma exacerbations were recorded, no work, school, or daycare days were missed by caregiver or participant due to asthma, coughing symptom score was \\<=1 and wheezing symptom score was 0. The mean percentages of asthma control days over the months 1-6 (defined as treatment days 2-182) are summarized. Number of participants over treatment days 2-182 from mITT Population were included for this endpoint.", "populationDescription": "mITT Population", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Error", "unitOfMeasure": "Percentage of asthma control days", "timeFrame": "From Day 1 up to 6 months", "groups": [{"id": "OG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment."}, {"id": "OG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "2936"}, {"groupId": "OG001", "value": "2935"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "74.8", "spread": "0.57"}, {"groupId": "OG001", "value": "73.4", "spread": "0.58"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Serious adverse events (SAEs) and non-serious adverse events (AEs) were collected from the start of study medication until follow-up (up to 6 months).", "description": "Due to the extensive safety database of FSC, FP, and albuterol/salbutamol, and the outcomes of interest in this study, the only non-serious AEs that were collected in this study are those that lead to study drug discontinuation.", "eventGroups": [{"id": "EG000", "title": "FSC DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of following treatments: FSC 100/50 microgram (\u00b5g) or FSC 250/50 \u00b5g as one inhalation twice daily (BID) (approximately 12 hours apart) via Dry powder inhaler (DPI) during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via metered dose inhaler (MDI) was permitted during study treatment.", "seriousNumAffected": 56, "seriousNumAtRisk": 3107, "otherNumAffected": 31, "otherNumAtRisk": 3107}, {"id": "EG001", "title": "FP DPI", "description": "Participants were randomized to either FSC or FP, and the treatment dose was based on participants' asthma control status. There was no intent to compare the dosage levels received, therefore participants were combined for comparison regardless of dosage. In this treatment arm, participants received one of the following treatments: FP 100 \u00b5g or FP 250 \u00b5g as one inhalation BID (approximately 12 hours apart) via DPI during the 6 month treatment period. Rescue medication (albuterol/salbutamol) via MDI was permitted during study treatment.", "seriousNumAffected": 54, "seriousNumAtRisk": 3101, "otherNumAffected": 39, "otherNumAtRisk": 3101}], "seriousEvents": [{"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 8, "numAtRisk": 3101}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 3, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 3101}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 3101}]}, {"term": "Appendicitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 3101}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Pharyngotonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Pneumonia viral", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 3101}]}, {"term": "Viral infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Abscess limb", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Acute sinusitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Bullous impetigo", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Eczema infected", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Infectious mononucleosis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Influenza", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Meningitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Peritonitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Pharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Pharyngitis streptococcal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Pseudocroup", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Viral myositis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Viral tonsillitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 23, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 13, "numAtRisk": 3101}]}, {"term": "Bronchial hyperreactivity", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Concussion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 3101}]}, {"term": "Animal bite", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Femur fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Forearm fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Laceration", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Post procedural complication", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Postoperative fever", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Road traffic accident", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Shunt malfunction", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Skull fractured base", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Tibia fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Upper limb fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Abdominal pain", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 3101}]}, {"term": "Gastritis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Colitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Constipation", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Enterocolitis", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Anaphylactic shock", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Drug hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Hypersensitivity", "organSystem": "Immune system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Haematuria", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Nephritis", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Urinary tract disorder", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Lymphadenitis", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Arrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Effusion", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Hepatitis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Metabolic disorder", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Synovitis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Henoch-Schonlein purpura", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}], "otherEvents": [{"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 15, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 23, "numAtRisk": 3101}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 3101}]}, {"term": "Wheezing", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Bronchospasm", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Nasal congestion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Oropharyngeal pain", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Pharyngeal inflammation", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Rhinitis allergic", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Upper respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Lower respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Pharyngitis streptococcal", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Rhinitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 2, "numAtRisk": 3101}]}, {"term": "Tremor", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Psychomotor hyperactivity", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Insomnia", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 2, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Irritability", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Abnormal behaviour", "organSystem": "Psychiatric disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Urticaria", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Eczema", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Pityriasis rosea", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Palpitations", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Eye swelling", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 3101}]}, {"term": "Chest discomfort", "organSystem": "General disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}, {"term": "Juvenile idiopathic arthritis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 3107}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 3101}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "GSK agreements may vary with individual investigators, but will not prohibit any investigator from publishing. GSK supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."}, "pointOfContact": {"title": "GSK Response Center", "organization": "GlaxoSmithKline", "phone": "866-435-7343"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["Czech Republic"]}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000068298", "term": "Fluticasone"}, {"id": "C000716389", "term": "Xhance"}, {"id": "D000068297", "term": "Fluticasone-Salmeterol Drug Combination"}], "ancestors": [{"id": "D000001993", "term": "Bronchodilator Agents"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000013566", "term": "Sympathomimetics"}, {"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000003879", "term": "Dermatologic Agents"}, {"id": "D000018926", "term": "Anti-Allergic Agents"}], "browseLeaves": [{"id": "M250", "name": "Fluticasone", "asFound": "Desensitization", "relevance": "HIGH"}, {"id": "M353494", "name": "Xhance", "asFound": "Desensitization", "relevance": "HIGH"}, {"id": "M251", "name": "Salmeterol Xinafoate", "relevance": "LOW"}, {"id": "M249", "name": "Fluticasone-Salmeterol Drug Combination", "asFound": "Steady state", "relevance": "HIGH"}, {"id": "M5269", "name": "Bronchodilator Agents", "relevance": "LOW"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M16345", "name": "Sympathomimetics", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M7074", "name": "Dermatologic Agents", "relevance": "LOW"}, {"id": "M20962", "name": "Anti-Allergic Agents", "relevance": "LOW"}], "browseBranches": [{"abbrev": "AAll", "name": "Anti-Allergic Agents"}, {"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "Derm", "name": "Dermatologic Agents"}, {"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}